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1. Introduction
Aflatoxins family includes a great number of lipophilic molecules produced by aerobic mi‐
croscopic fungi belonging to the genus Aspergillus. The chapter describes their chemical
structure, chemical and physical properties, and aspects related to their presence in food
and commodities. Aflatoxins presence in food is considered a real and severe risk to con‐
sumers for their toxicity. Aflatoxins levels and frequency of foods natural contamination as
reported in the scientific literature are briefly analyzed. Focus is given to the different food‐
stuffs that may be at risk of contamination by Aspergillus and the subsequent accumulation
of aflatoxins in the food chain. Bioavailability and bioaccessibility of aflatoxins will be dis‐
cussed considering that these unwanted molecules can be assumed by the humans with the
diet. Bioaccessibility, that deals with the fraction of micro-nutrients released from the food
matrix during digestion and gastro-intestinal available for absorption, will be discussed
with reference to aflatoxins bioaccessibility of during the digestion process, considering the
relationships between the food matrix and its influences on aflatoxins fate. Bioavailability of
the aflatoxins assumed from the diet depends on their stability during digestion, since they
are released from the food matrix (bioaccessibility) and on the efficiency of their passage
through the gastro-intestinal mucosa. The term bioavailability includes the concepts of
availability to the absorption, metabolism, distribution of nutrients to tissues and bioactivity
and indicates the fraction of micro-nutrients absorbed by the body and the speed with
which these molecules are absorbed and made available at their site of action. Despite of the
practical difficulties in measuring the distribution and bioactivity of aflatoxins on a specific
human body organ, the bioavailability is the fraction of an oral dose of a compound or pre‐
cursor of an active metabolite that reaches the bloodstream. Bioaccessibility includes the en‐
tire sequence of events that take place during the digestion of food material that can be
assimilated by the body through the epithelial cells of the gastro-intestinal mucosa. Aflatox‐
ins are often present in very small amounts or in traces and, for this reason, a part of the
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chapter addresses the advanced new chromatographic and spectrometric methods descri‐
bed in the literature and applied to research, that can reveal, even in trace amounts, aflatox‐
ins in biological fluids as free form or as by-products, e.g. non-covalent adducts.
2. Structure and chemistry of aflatoxins
Aflatoxins were isolated and characterized after the Turkey X desease, that caused the death of
more than 100.000 turkey poultries due to the intake of a contaminated peanut meal produced
in South America starting from contaminated raw material (Blout, 1961; Goldblatt, 1969).
The most important aflatoxins, among the about 13 compounds so far identified, are the afla‐
toxin B1 and B2, the aflatoxin G1 and G2 and the aflatoxin metabolic byproducts M1 and M2. The
four major aflatoxins are called B1, B2, G1, and G2 based on their fluorescence under UV light
(blue or green) and relative chromatographic mobility during thin-layer chromatography. Fig‐
ure 1 shows the chemical structures of the main aflatoxins. Their chemical structure incorpo‐
rates dihydrofuran and tetrahydrofuran moieties coupled to a substituted coumarin. They are
produced by a polyketide pathway by many strains of Aspergillus flavus and Aspergillus parasit‐
icus; in particular, Aspergillus flavus is a common contaminant in agriculture. Aspergillus bomby‐
cis, Aspergillus ochraceoroseus, Aspergillus nomius, and Aspergillus pseudotamari are also aflatoxin-
producing species, but they are encountered less frequently (Goto, Wicklow, Ito, 1996; Klich,
Mullaney, Daly, Cary, 2000; Peterson, Ito, Horn, Goto, 2001). Table 1 gives some relevant chem‐
ical properties of these compounds. Aflatoxin B1 is considered the most toxic and is produced,
together with aflatoxin B2 by both Aspergillus flavus and Aspergillus parasiticus. Aflatoxin G1 and
G2 are produced exclusively by Aspergillus parasiticus. While the presence of Aspergillus spp. in
food products does not always indicate harmful levels of aflatoxins are also present, it does im‐
ply a significant risk in consumption. Aflatoxins M1 and M2 were originally discovered in the
milk of cows which fed on moldy grain. Aflatoxin M1 has been observed also in the fermenta‐
tion broth of Aspergillus parasiticus. These compounds are products of a conversion process in
the animal's liver that try to make these molecules more hydrophilic to be easily excreted from
body via the kidney. Aflatoxin M1 is a metabolite of aflatoxin B1 in humans and animals where
exposure at ng levels can come from mother's milk. Similarly, aflatoxin M2 is a metabolite of
aflatoxin B2 in milk of cattle fed on contaminated food (Tara, 2005). Other metabolites can de‐
rive from these main ones, like Aflatoxicol, that forms by biological reduction of aflatoxin B1
(Pawlowski, Schoenhard, Lee, Libbey, Loveland, Sinnhuber, 1977). The levels considered safe
for these compounds are reported in Table 2. Aflatoxin B1 is the most potent natural carcinogen
known, and is probably also the most studied aflatoxin being often the major aflatoxin pro‐
duced by toxigenic strains (Squire, R. A. 1981). For this reason, it is also the best studied: in a
large percentage of the papers published the term aflatoxin can be assumed to refer to aflatoxin
B1. However, many other aflatoxins (e.g., P1. Q1, B2a, and G2a) have been described, especially as
mammalian biotransformation products of the major metabolites (Heathcote, Hibbert, 1978).
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Aflatoxin MW (g/ mol) Formula Melting point
(°C)
IUPAC name
B1 312.28 C17H12O6 268–269
2,3,6a,9a-tetrahydro-4-methoxycyclopenta(c)furo(3',2':
4,5)furo(2,3-h)(1)benzo-pyran-1,11-dione
B2 314.29 C17H14O6 286–289
2,3,6aa,8,9,9aa-Hexahydro-4-methoxycyclopenta(c)furo(2',3':
4,5)furo(2,3-h)chromene-1,11-dione
G1 328.28 C17H12O7 244-246
7AR,cis)3,4,7a,10a-tetrahydro-5-methoxy-1H,12H-furo(3',2':
4,5)furo(2,3-h)pyrano(3,4-c)chromene-1,12-dione
G2 330.29 C17H14O7 237–240
1H,12H-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)
(1)benzopyran-1,12-dione
M1 328.28 C17H12O7 299
(6AR-cis)-2,3,6a,9a-tetrahydro-9a-hydroxy-4-
methoxycyclopenta(c)furo(3',2':4,5)furo(2,3-h)
(1)benzopyran-1,11-dione
M2 330.29 C17H14O7 293
2,3,6a,8,9,9a-Hexahydro-9a-hydroxy-4-
methoxycyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)
benzopyran-1,11-dione
Table 1. Chemical relevant data for main aflatoxins (O’Neil, Smith, Heckelman, 2001).
Figure 1. Chemical structures of the main aflatoxins.
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µg/kg Food
20 Food addressed to humans consumption. Corn and grains for animal feeds.
100 Corn and grains for breeding beef cattle, breeding swine, or poultry.
200 Corn and grains intended for swine.
300 Corn and grains for finishing beef cattle, swine, poultry.
Table 2. Aflatoxins levels limits generally considered as safe.
3. Biosynthesis of aflatoxins
Many relevant aspects of aflatoxins biosynthesis and molecular biology have been studied
and extensively described. The first step in the biosynthetic pathway is considered the pro‐
duction of norsolorinic acid, an anthraquinone precursor, by a type II polyketide synthase.
A series of about 15 post-polyketide synthase steps follows, yielding increasingly toxigenic
metabolites (Bennett, Chang, Bhatnagar, 1997; Cleveland, Bhatnagar, 1992; Hicks, Shimizu,
Keller, 2002; Payne, Brown, 1998; Townsend, 1997; Trail, Mahanti, Linz, 1995). Sterigmato‐
cystin, a related dihydrofuran toxin, mutagenic and tumorigenic but less potent than afla‐
toxin (Berry, 1988), is a late metabolite in the aflatoxin pathway, and is also produced as a
final biosynthetic product by a number of species like Aspergillus versicolor and Aspergillus
nidulans. Analysis of the molecular genetics of sterigmatocystin biosynthesis in the genetical‐
ly tractable species Aspergillus nidulans has provided a useful model system. The genes for
the sterigmatocystin gene cluster from Aspergillus nidulans have been cloned and sequenced
(Brown, Yu, Kelkar, Fernandes, Nesbitt, Keller, Adams, Leonard, 1996). Cognate genes for
aflatoxins pathway enzymes from Aspergillus flavus and Aspergillus parasiticus show high se‐
quence similarity to the sterigmatocystin pathway genes (Payne, Brown, 1998; Yu, Chang,
Bhatnagar, Cleveland, 2000; Yu, Woloshuk, Bhatnagar, Cleveland, 2000). Genes organization
for Aspergillus flavus, Aspergillus nidulans, and Aspergillus parasiticus sterigmatocystin-aflatox‐
in pathway has been studied as reported by Cary et al. (Cary, Chang, Bhatnagar, 2001) and
Hicks et al. (Hicks, Shimizu, Keller, 2002).
Aspergillus oryzae and Aspergillus sojae, species that are widely used in Asian food fermenta‐
tions such as soy sauce, miso, and sake, are closely related to the aflatoxigenic species Asper‐
gillus flavus and Aspergillus parasiticus. Although these food fungi have never been shown to
produce aflatoxin (Wei, Jong. 1986), they contain homologues of several aflatoxin biosynthe‐
sis pathway genes (Klich, Yu, Chang, Mullaney, Bhatnagar, Cleveland, 1995). Deletions and
other genetic defects have led to silencing of the aflatoxin pathway in both Aspergillus oryzae
and Aspergillus sojae (Takahashi, Chang, Matsushima, Abe, Bhatnagar, Cleveland, Koyama,
2002; Watson, Fuller, Jeens, Archer, 1999; Bennett, Klich, 2003).
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4. Frequency and levels of contamination in food
Aflatoxins have received greater attention than any other mycotoxins because of their dem‐
onstrated potent carcinogenic effect in susceptible laboratory animals and their acute toxico‐
logical effects in humans. Many countries have attempted to limit exposure to aflatoxins by
imposing regulatory limits on commodities to be used as food and feed. The two species of
Aspergillus fungi, aflatoxin producing, are especially found in areas with hot and humid cli‐
mate. Since aflatoxins are known to be genotoxic and carcinogenic, exposure through food
should be kept as low as possible. Aflatoxins have been also associated with various diseas‐
es, such as aflatoxicosis. Aflatoxin B1 is the most common in food, and has the most potent
genotoxic and carcinogenic effects. Aflatoxin M1 is a major metabolite of aflatoxin B1 in hu‐
mans and animals, which may be present in milk from animals fed with aflatoxin B1 conta‐
minated feed. Aflatoxins can occur in foods, such as groundnuts, treenuts, maize, rice, figs,
grapes, raisins, and other dried foods, spices and crude vegetable oils, and cocoa beans, as a
result of fungal contamination before and after harvest. The biosynthesis and the occurrence
of aflatoxins is influenced by environmental factors; consequently the extent of contamina‐
tion varies with geographic location, agricultural and agronomic practices. The susceptibili‐
ty of commodities to fungal invasion during preharvest, storage, and/or processing periods
is also important to assess the possible contamination.
5. Aflatoxins in food and commodities
From the mycological perspective, there are great qualitative and quantitative differences in
the toxigenic abilities displayed by different strains within each aflatoxigenic species. For ex‐
ample, only about half of Aspergillus flavus strains produce aflatoxins (Klich, Pitt, 1988),
while those that do may produce more than 106 µg/kg (Cotty, Bayman, Egel, Elias, 1994).
Many substrates support growth and aflatoxin production by aflatoxigenic molds. Natural
contamination of cereals, figs, oilseeds, nuts, tobacco, and a long list of other commodities is
a common occurrence (Detroy, Lillehoj, Ciegler, 1971; Diener, Cole, Sanders, Payne, Lee,
Klich, 1987).
Crops can be contaminated with aflatoxins in the field before harvest (Diener, Cole, Sanders,
Payne, Lee, Klich, 1987; Klich, 1987). Even more problematic is the fate of crops stored under
conditions that favor mold growth. The most relevant variables to keep under control dur‐
ing the storage are considered the moisture content of the substrate and the relative humidi‐
ty of the surroundings (Detroy, Lillehoj, Ciegler, 1971; Wilson, Payne, 1994). There are many
side implications of aflatoxins contamination. Aflatoxin contamination has been linked to in‐
creased mortality in farm animals and thus significantly lowers the value of grains as an ani‐
mal feed and as an export commodity (Smith, Moss, 1985). Milk products can also be an
indirect source of information on aflatoxins presence in the diet, and considering the broad
diffusion of these products mainly addressed to infants, children, and people affected by
health conditions, the risk associated to aflatoxins M1 and M2 is relevant. When cows assume
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aflatoxin-contaminated feed, they metabolically biotransform aflatoxin B1 into a hydroxylat‐
ed form, namely aflatoxin M1, as a detoxification way for animal exposed to aflatoxins B1 or
B2 (Van Egmond, 1989).
6. Occurence
Aflatoxins often occur in crops in the field before harvest so frequently that they are consid‐
ered mycotoxins originating from the field compared to other mycotoxins that are common‐
ly found in post-harvesting of field crops. Postharvest contamination can occur if crop
drying is delayed and during crop storage if water is present in the amount required for the
mold growth. Insect or rodent presence can facilitate mold onset on stored commodities.
Aflatoxins have been also detected in milk, cheese, corn, peanuts, cottonseed, nuts, almonds,
figs, grape berries, spices, and a variety of other foods and feeds. Milk, eggs and meat prod‐
ucts are contaminated sometimes due to the consumption by the animal of aflatoxin conta‐
minated feed, and are a clear example of carry-over. A few years after the discovery of
mycotoxins, scientific understanding of the carry-over phenomenon raised immediately the
interest of scientists and put focus on the risk related to food contaminated by molds. The
commodities with the highest risk of aflatoxin contamination are corn, peanuts, and cotton‐
seed. Corn is probably the commodity of greatest worldwide concern, because it is grown in
climates that are likely to have perennial contamination with aflatoxins. Corn is the staple
food of many countries, and, also for some population corn represents the main ingredient
of the diet. It is usually named as single-food with all nutritional and unwanted contami‐
nants related to its consumption. Corn can be used to produce flour and starch products and
this links back to the problem statement such as aflatoxins is a likely toxin to be found in
foodstuff. However, procedures used in the processing of corn help to reduce contamination
of the resulting food product. This is because although aflatoxins are stable to moderately
stable in most food processes, they are unstable in processes such as those used in making
tortillas that employ alkaline conditions or oxidizing steps. Aflatoxin-contaminated corn
and cottonseed meal in dairy rations have resulted in aflatoxin M1 contaminated milk and
milk products, including non-fat dry milk, cheese, ice creams and yogurts. Even in the case
of the butter, during its production due to its chemical lipid rich compostion, the accumula‐
tion and concentration of any aflatoxin M1 present in milk is usually involved.
7. Aflatoxins toxicity
Aflatoxins, and especially aflatoxin B1, are associated with both toxicity and carcinogenicity in
human and animal populations. The International Agency for Research on Cancer has classi‐
fied aflatoxin B1 as a group I carcinogen (International Agency for Research on Cancer, 1982).
In particular, aflatoxin B1 is considered by medicine doctors and toxicologists as the most
hepatocarcinogenic compound not produced by human activites but produced by a life or‐
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ganism (Newberne, Butler, 1969; Shank, Bhamarapravati, Gordon, Wogan, 1972; Peers, Lin‐
sell, 1973; Eaton, Groopman, 1994). The diseases caused by aflatoxin consumption are
loosely called aflatoxicoses. Acute aflatoxicosis results in death; chronic aflatoxicosis results
in cancer, immune suppression, and other "slow" pathological conditions (Hsieh, 1988). The
liver is the primary target organ, with liver damage occurring when poultry, fish, rodents,
and non human primates are fed aflatoxin B1 contaminated foodstuff. This data is not unex‐
pected because the liver is a lipophilic organ and all compounds carried by blood stream, i.e.
drugs, contaminants, mycotoxins etc., are stored and concentrated in the hepatocytes that,
with a long exposure time, may transform themselves in a cancer cell line. There are sub‐
stantial differences in species susceptibility. Moreover, within a given species, the magni‐
tude of the response is influenced by age, sex, weight, diet, exposure to infectious agents,
and the presence of other mycotoxins and pharmacologically active substances. Thousands
of studies on aflatoxin toxicity have been conducted, mostly on laboratory models or agri‐
cultural important species (Cullen, Newberne, 1994; Eaton, Groopman, 1994; Newberne,
Butler, 1969).
Cytochrome  P450  enzymes  convert  aflatoxins  to  the  reactive  8,9-epoxide  form  (also
known as aflatoxin-2,3 epoxide),  which is capable of binding to both DNA and proteins
(Eaton, Groopman, 1994). The reactive aflatoxin epoxide binds to the N7  position of gua‐
nines.  Moreover,  aflatoxin B1-DNA adducts  can result  in GC to TA transversions.  A re‐
active  glutathione  S-transferase  system  found  in  the  cytosol  and  microsomes  catalyzes
the conjugation of activated aflatoxins with reduced glutathione, leading to the excretion
of  aflatoxins  (Raj,  Prasanna,  Mage,  Lotlikar,  1986).  Variation  in  the  level  of  the  gluta‐
thione transferase  system as  well  as  variations  in  the  cytochrome P450 system are  con‐
sidered  contributor  to  the  differences  observed  in  interspecies  aflatoxin  susceptibility
(Eaton, Ramsdel, 1992; Eaton, Groopman, 1994).
Considering the differences exhisting in aflatoxin susceptibility in test animals, it has been
proven not easy to extrapolate the possible effects of aflatoxins to humans. Acute toxicity of
aflatoxins in humans however represent a serious threat.
In 1974 it has been reported in India an outbreak of hepatitis and 100 cases of death attribut‐
ed to the consumption is heavily aflatoxins contaminated maize, causing an aflatoxins in‐
take of 2 to 6 mg per day (Krishnamachari, Bhat, Nagarajan, Tilnak, 1975). Based on these
data, it has been estimated that the acute lethal dose (LD) for adults is approximately 10 to
20 mg of aflatoxins (Pitt, 2000). Aflatoxins have been in years associated to various health
conditions and are considered a poison. For example it has been associated kwashiorkor, a
severe malnutrition disease, to a form of pediatric aflatoxicosis (Hendrickse, 1997). Aflatox‐
ins, according to reported studies non completely assessed, could be involved in Reye's syn‐
drome, an encephalopathy, and to fatty degeneration of some target organs in children and
adolescents (Hayes, 1980).
Exposure to aflatoxins in the diet is considered an important risk factor for the development of
primary hepatocellular carcinoma, particularly in individuals already exposed to hepatitis B.
There are also observed nonhepatic effects of aflatoxin B1 as reported by Coulombe (Cou‐
lombe, 1994). Several epidemiological studies have linked liver cancer incidence to estimated
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aflatoxin consumption in the diet (Peers, Linsell, 1973; Van Rensburg, Cook-Mazaffari, van
Schalkwyk, van der Watt, Vincent, Purchase, 1985; Li, Yoshizawa, Kawamura, Luo, Li, 2001)
even if the long term quantification of individual exposure to aflatoxins is difficult. The inci‐
dence of liver cancer varies widely from country to country, but it is one of the most common
occurring in China, the Philippines, Thailand, and many African countries. The presence of
hepatitis B virus infection, an important risk factor for primary liver cancer, complicates many
of the epidemiological studies. In one case-control study involving more than 18.000 urine
samples collected over 3.5 years in Shanghai, China, aflatoxin exposure alone yielded a relative
risk of about 2; hepatitis B virus antigen alone yielded a relative risk of about 5; combined expo‐
sure to aflatoxin and hepatitis B yielded a relative risk of about 60 (Ross, Yuan, Yu, Wogan,
Qian, Tu, Groopman, Gao, Henderson, 1992).
Using molecular epidemiology, it is possible to asses a link exhisting between putative carci‐
nogens and specific cancers. Biomonitoring of aflatoxins can be done by analyzing for the
presence of aflatoxin metabolites in blood, milk, and urine. In addition, excreted DNA ad‐
ducts and blood protein adducts can also be monitored (Sabbioni, Sepai, 1994). The aflatoxin
B1-N7-guanine adduct is considered a reliable urinary biomarker for aflatoxin exposure but
reflects only recent exposure. Many studies have shown that carcinogenic potency is highly
correlated with the extent of total DNA adducts formed in vivo (Eaton, Gallagher, 1994; Ea‐
ton, Groopman, 1994).
Inactivation of the p53 tumor suppressor gene may be important in the development of pri‐
mary hepatocellular carcinoma. Studies of liver cancer patients in Africa and China have
shown that a mutation in the p53 tumor suppressor gene at codon 249 is associated with a
G-to-T transversion (Bressac, Kew, Wands, Ozturk, 1991; Hsu, Metcalf, Sun, Welsh, Wang,
Harris, 1991). It is known that the reactive aflatoxin epoxide binds to the N7 position of gua‐
nines. Moreover, aflatoxin B1-DNA adducts can result in GC to TA inversion. The specific
mutation in codon 249 of the p53 gene has been called the first example of a "carcinogen-
specific" biomarker that remains fixed in the tumor tissue (Eaton, Gallagher, 1994).
There is also considerable evidence associating aflatoxin with neoplasms in extrahepatic tis‐
sues, particularly the lungs. For example, one early epidemiological study of Dutch peanut
processing workers exposed to dust contaminated with aflatoxin B1 showed a correlation be‐
tween both respiratory cancer and total cancer in the exposed group compared with unex‐
posed cohorts (Hayes, van Nienwenhuise, Raatgever, Ten Kate, 1984). Exposition even
indirect to aflatoxins can result in a severe health issue: Deger (Deger, 1976) reported for ex‐
ample that dust from scrapings of chromatographic plates from aflatoxin analyses contribut‐
ed to causing cancer in two young adults.
In developed countries, sufficient amounts of food combined with regulations that monitor
aflatoxin levels protect human populations from significant aflatoxins ingestion. However, in
countries where populations are facing starvation or where regulations are either not enforced
or nonexistent, routine ingestion of aflatoxin may occur (Cotty, Bayman, Egel, Elias, 1994).
Worldwide, liver cancer incidence rates are 2 to 10 times higher in developing countries than in
developed countries (Henry, Bosch, Troxell, Bolger, 1999). A joint Food and Agriculture Or‐
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ganization/World Health Organization/United Nations Environment Programme Conference
report stated that "in developing countries, where food supplies are already limited, drastic le‐
gal measure may lead to lack of food and to excessive prices. It must be remembered that peo‐
ple living in these countries cannot exercise the option of starving to death today in order to live
a better life tomorrow" (Henry, Bosch,. Troxell, Bolger, 1999).
8. Monitoring techniques for assessing human exposure to aflatoxins
In the last few years, new technologies have been developed that more accurately monitor
individual exposures to aflatoxins. Particular attention has been paid to the analysis of afla‐
toxin DNA adducts and albumin adducts as surrogates for genotoxicity in people. Autrup et
al. (Autrup, Bradly, Shamsuddin, Wakhisi, Wasunna, 1983) proposed for the first time the
use of synchronous fluorescence spectroscopy for the measurement of aflatoxin DNA ad‐
ducts in urine. Urine samples collected after exposure to alfatoxins were found to contain
2,3-dihydroxy-2-(N7-guanyl)-3-hydroxyaflatoxin B1, trivially known as aflatoxin B-Gual.
Wild et al. used highly sensitive immunoassays to quantitate aflatoxins in human body flu‐
ids (Wild, Umbenhauer, Chapot, Montesano, 1986).
An enzyme linked immunosorbent assay (ELISA) was used to quantitate aflatoxin B1 in a range
from 0.01 ng/mL to 10 ng/mL, and was validated in human urine samples. Using this method,
aflatoxin-DNA adduct excretion into urine was found to be positively correlated with dietary
intake, and the major aflatoxin B1-DNA adduct excreted in urine was shown to be an appropri‐
ate dosimeter for monitoring aflatoxin dietary exposure. Several epidemiological studies have
found positive association between aflatoxin B1 dietary exposure and an increased risk of hu‐
man liver cancer (Sudakin, 2003; Zhu, Zhang, Hu, Xiao, Chen, Xu, Fremy, Chu, 1987; Groop‐
man,  Donahue,1988;  Bean,  Yourtee,  1989).  Cytochrome  P-450  enzymes  further  convert
aflatoxins to different metabolites (Eaton, Ramsdell, Neal, 1994), e.g. aflatoxin B1 is converted
to metabolites like aflatoxin B1-epoxide and the hydroxylated aflatoxins M1, P1 and Q1. The hy‐
droxylated metabolites form glucuronide and sulfate conjugates that can be enzymatically hy‐
drolysed by b-glucuronidase and sulfatase (Wei, Marshall, Hsieh, 1985).
The European Union (EU) introduced measures to minimise the presence of aflatoxins in
different foodstuffs. Maximum levels of aflatoxins are laid down in Commission Regulation
(EC) No. 1881/2006. In an opinion adopted in January 2007, the European Food Safety Au‐
thority (EFSA) scientific Panel on contaminants in the food chain (CONTAM), concluded
that increasing the current EU maximum levels of 4 µg/kg total aflatoxins in nuts to 8 or 10
µg/kg total afatoxins would have had minor effects on the estimated dietary exposure, can‐
cer risk and calculated margin of exposure. The Panel also concluded that exposure to afla‐
toxins from all food sources should be kept as low as reasonably achievable because
aflatoxins are genotoxic and carcinogenic. In June 2009 the European Commission asked EF‐
SA to assess the effect on public health of an increase of the maximum level for total aflatox‐
ins from 4 µg/kg to 10 µg/kg allowed for tree nuts other than almonds, hazelnuts and
pistachios (e.g. Brazil nuts and cashews). This would facilitate the enforcement of the maxi‐
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mum levels, in particular regarding commercially available mixtures of nuts. The Panel con‐
cluded that public health would not be adversely affected by increasing the levels for total
aflatoxins from 4 µg/kg to 8 or 10 µg/kg. However, the Panel reiterated its previous conclu‐
sions regarding the importance of reducing the number of highly contaminated foods reach‐
ing the market.
9. Bioavailability
In human health risk assessment, ingestion of contaminated food is considered a major
route of exposure to many contaminants either caused by industrial or environmental con‐
tamination or as result of production processes. The total amount of an ingested contami‐
nant (intake) does not always reflect the amount that is available to the body. Only a certain
amount of the contaminant will be bioavailable (Versantvoort, Oomen, Van de Kamp, Rom‐
pelberg, Sips, 2005). Bioavailability is a term used to describe the proportion of the ingested
contaminant in food that reaches the systemic circulation and then the organ or the appara‐
tus. Studies in animals and humans show that oral bioavailability of compounds from food
can be significantly different depending on the food source (food product), food processing
or food preparation (Wienk, Marx, Beynen, 1999; van het Hof, West, Weststrate, Hautvast,
2000). As a consequence, the intake of a contaminant in food matrix A can lead to toxicity
whereas the intake of the same amount of contaminant in food matrix B will not exert a toxic
effects. Thus, a better insight in the effect of the matrix on the oral bioavailability of a con‐
taminant will lead to a more accurate health risk assessment (Versantvoort, Oomen, Van de
Kamp, Rompelberg, Sips, 2005).
Oral bioavailability of a compound can be seen as the resultant of three processes, namely
the release of the compound from its matrix into digestive juice in the gastrointestinal tract
(bioaccessibility); the transport across the intestinal epithelium into the vena Portae (intesti‐
nal transport); and the degradation of the compound in the liver and intestine (metabolism).
Release of the contaminant from the ingested product in the gastrointestinal tract is a pre‐
requisite for uptake and bioavailability of a contaminant in the body. The oral bioavailability
of the contaminant can be reduced subsequently by partial transport of the contaminant
across the intestinal epithelium, or by degradation of the contaminant. Thus, determination
of the bioaccessibility of a contaminant from its matrix can be seen as an indicator for the
maximal oral bioavailability of the contaminant. Quantification of bioavailability and bioac‐
cessibility of a compound from a certain matrix is difficult and often hampered by complex
processes comprising digestion. The last decade there is an increasing interest in the use of
in vitro methodologies to study the human oral bioavailability of compounds from the food
chain (Minekus, Marteau, Havenaar, Huis, 1995; Glahn, Wien, Van Campen, Miller, 1996;
Garrett, Failla, Sarama, 1999; Ruby, Schoof, Brattin, Goldade, Post, Harnois, Mosby, Casteel,
Berti, Carpenter, Edwards, Cragin, Chappell, 1999; Oomen, Hack, Minekus, Zeijdner, Corne‐
lis, Schoeters, Verstraete, Wiele, Wragg, Rompelberg, Sips, Wijnen, 2002).
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Most of the in vitro digestion models simulate in a simplified manner the digestion processes
in mouth, stomach and small intestine, in order to enable investigation of the bioaccessibility
of compounds from their matrix during transit in the gastrointestinal tract.
Extensive studies involving animal models have indicated that the primary site for absorp‐
tion of aflatoxin is the small intestine, in particular the duodenum (Wogan, Edwards, Shank,
1967; Ramos, Hernandez, 1996). Lactobacillus spp. has previously proven to be capable to sur‐
vive at the gastrointestinal tract after oral intake (Taranto, Medici, Perdigon, Ruiz-Holgado,
Valdez, 2000; Valeur, Engel, Carbajal, Connolly, Ladefoged, 2004); therefore, it is probable
that mycotoxins were in contact with bacteria in the intestinal lumen, which then favored
aflatoxin B1 binding by bacteria prior to its natu ral process of absorption.
It has been reported that the binding process might be dependent on the environmental pH
(Bolognani, Rumney, Rowland, 1997) and that the presence of bile salts could produce sig‐
nificant effects in the aflatoxin B1 binding ability of the bacteria (Hernandez-Mendoza, Gar‐
cia, Steele, 2009). These two factors are closely related during the normal digestive process
and its relationship varies along the small intestine (Low, 1990). Hence, the difference on
aflatoxin binding ability of Lactobacillus spp. observed at the different portions of the intes‐
tine could be influenced by conditions prevailing in each region of the gastrointestinal tract.
Once the aflatoxin B1 has been absorbed at intestinal level, it proceeds to the bloodstream
and binds with plasma proteins especially albumin to form aflatoxin B1-albumin adduct
(Verma, 2004). The average half-life of albumin (approximately 20 days in humans) allows
accumulation of adducts after chronic exposure to the toxin (Chapot, Wild, 1991). According
to this, the amount of adducts present in blood samples of rats treated only with aflatoxin B1
represent the cumulative dose of aflatoxin intake over the experimental period, which indi‐
cates that the reduction of aflatoxin B1-Lys adduct observed in animals treated with aflatoxin
plus bacteria was originated by the ability of Lactobacillus spp.to bind aflatoxin B1 inside the
intestinal lumen, thus avoiding its passage into the bloodstream. In a related work (Gratz,
Täubel, Juvonen, Viluksela, Turner, 2006) no significant differences were found in the
amounts of aflatoxin B1-Lys adduct present in animals receiving Lactobacillus rhamnosus GG
daily for 3 d before and 3 d after a single oral dose of aflatoxin B1 compared with those re‐
ceiving only the mycotoxin. Other reports suggested that probiotics are less capable of bind‐
ing aflatoxin B1 in the presence of mucus and are more susceptible to interfere factors in the
intestinal tract, which may explain the behavior observed in the levels of adduct (Gratz,
Mykkänen, Ouwehand, Juvonen, Salminen, 2004; Gratz, Täubel, Juvonen, Viluksela, Turner,
2006). This effect could have been surmounted by the numbers of bacteria implanted before
oral dose of aflatoxin B1, and the constant administration of probiotic bacteria during the ex‐
perimental period (Gratz, Mykkänen, Ouwehand, Juvonen, Salminen, 2004).
In agreement with earlier reports (Ward, Sontag, Weisburger, Brown, 1975; Maurice, Bodine,
Rehrer, 1983), body weight gain was not adversely affected. However, there was a reduction
in feed intake in rats receiving only aflatoxin B1. This effect could be induced by the dose of
aflatoxin received, since it has been reported that aflatoxin B1 induces reduction of food in‐
take in some animal species, including rats and birds, in a dose-dependent manner (Maur‐
ice, Bodine, Rehrer, 1983). In addition, toxicological studies in rats have shown that aflatoxin
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B1 consumption may produce a significant decrease of serum leptin levels (Abdel-Wahhab,
Ahmed, Hagazi, 2006). Leptin concentration is usually associated with the high levels of cor‐
tisol and interleukin-6, which act together to influence the feeding response (Barber, McMil‐
lan, Wallace, Ross, Preston, 2004). Lactobacillus reuteri might have contributed to reduce the
aflatoxin B1 absorption in bacteria-treated rats and thus diminish its effect on leptin levels in
blood serum.
The volume of the stomach is considered an important parameter for oral dosing in experi‐
mental animals. For rats, maximum oral dosage volume recommended is 10 mL kg–1 of body
weight; for a 200 g rat this would mean a dosing volume of 2 mL (McConnell, Basit, Mur‐
dan, 2008). Therefore, it is possible that the volume supplied (every third day) by oral gav‐
age of aflatoxin and/or bacteria over the experiment, had partially met the basic water needs
of the rats, which may explain the observed reduction in water consumption at the end of
the experimental period (21 days).
A  world-wide-accepted  method  for  protecting  animals  against  mycotoxicosis  is  the  use
of adsorbent materials. An effective adsorbent is one that tightly binds the mycotoxin in
contaminated  feed  without  dissociating  in  the  gastrointestinal  tract  of  the  animal.  The
toxin–adsorbent  complex  passes  then  through  the  gastrointestinal  tract  without  absorp‐
tion and is eliminated via the faeces. In other words, the bioavailability of the mycotox‐
in  is  reduced  as  less  mycotoxin  is  absorbed  because  it  is  bound  to  the  adsorbent,  i.e.
lower bioaccessibility. Therefore, these adsorbents can be used to evaluate the use of the
in vitro digestion model as indicator for the in vivo bioavailability.  The following mate‐
rials, representative for different classes of adsorbents, have been selected: an aluminosi‐
licate  (HSCAS),  which  is  a  common  anticaking  additive  in  animal  feeds  to  reduce
mycotoxicosis  in  animals;  activated  charcoal,  which  is  used  in  humans  and  animals  as
an antidote against poisoning; cholestyramine is an anion exchange resin and binds bile
acids in the gastrointestinal tract and it has been used for over 20 years in the clinic for
reduction of lowdensit y lipoproteins and cholesterol.
The effect of chlorophyllin on intestinal transport of aflatoxin B1 was studied by measure‐
ment of the transport of aflatoxin B1 with the intestinal Caco-2 cells. The rate at which com‐
pounds are transported across the Caco-2 cells, which is expressed as a permeability
coefficient, is correlated with absorption in humans (Artursson, Karlsson, 1991).
Transport of 5ng/mL aflatoxin B1 across Caco-2 cells revealed that after 4h, 25±6% aflatoxin
B1 was transported across Caco-2 cells into the basolateral compartment. Addition of chloro‐
phyllin (1 mg/mL) greatly reduced (>20-fold) the transport of aflatoxin B1 to only 1±1%.
From this transport, a permeability coefficient can be calculated for aflatoxin B1 of 9x10-6
cm/s in absence, and 0.4x10-6 cm/s in presence of chlorophyllin. When we compare these
transport rates with the S-shaped correlation found for absorption of compounds in hu‐
mans, the permeability coefficient of aflatoxin B1 alone (9x10-6 cm/s) corresponds with high
absorption in humans whereas the permeability coefficient of aflatoxin B1 in presence of
chlorophyllin (0.4x10-6 cm/s) indicates an intermediate absorption. Thus, these data are in ac‐
cordance with the human intervention study on chlorophyllin and aflatoxin B1, where a 50%
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reduction in excretion of aflatoxin metabolites in urine was found in presence of chlorophyl‐
lin (Versantvoort, Oomen, Van de Kamp, Rompelberg, Sips, 2005).
Furthermore, these results provide evidence for the hypothesis that chlorophyllin reduces
the absorption of aflatoxin B1 in humans.
In risk assessment, a dose proportional relationship between contamination level and bioa‐
vailability is taken as basic assumption. This assumption simplifies risk assessment, since it
can be assumed that regardless the level of contamination, a constant percentage of the con‐
taminant will be bioavailable. The extreme sensitivity of turkeys to the toxic effects of afla‐
toxin B1, a condition associated with a combination of efficient CYP-mediated activation and
deficient GST-mediated detoxification of aflatoxin B1 (Klein, Buckner, Kelly, Coulombe,
2000), makes turkeys an excellent model in which to study various chemopreventives. We
have recently shown that the observed chemopreventive properties of BHT in turkeys is
due, at least in part, to its ability to inhibit hepatic conversion of aflatoxin B1 to the exo-afla‐
toxin B1-8,9-epoxide (AFBO) in vivo and in vitro (Guarisco, Hall, Coulombe, 2008).
Determining the outcome of inhibition of hepatic aflatoxin B1 bioactivation in whole animals
is relevant to veterinary medicine and to food safety. Dietary butylated hydroxytoluene
(BHT) can reduce aflatoxin B1 bioavailability, as demonstrated by serum concentrations of
radiolabel which were reduced at every time interval after aflatoxin B1 administration.
Among the possible explanations for reduced bioavailability is high first pass elimination
prior to absorption into the blood, and/or an attenuation of mucosal aflatoxin B1 absorption.
However, since no quantitative difference in the biliary elimination of aflatoxin B1 or its me‐
tabolites was identified, any change due to increased first pass effect would have to result in
increased elimination by non-biliary pathways.
The observed reduction in hepatic aflatoxin B1–DNA adducts in BHT fed animals is consis‐
tent with the fact that this antioxidant is a competitive inhibitor of hepatic in vitro CYP1A5-
mediated aflatoxin B1 epoxidation to AFBO. Because of the critical role of AFBO and
subsequent adduct formation in aflatoxicosis (as well as longer-term consequences such as
tumor formation), a reduction in hepatic aflatoxin B1–DNA adducts would be expected to
have a positive effect on the overall health of aflatoxin B1-exposed turkeys.
10. Bioaccessibility
Bioaccessibility has been defined as the fraction of a compound that is released from its ma‐
trix in the gastrointestinal tract and thus becomes available for intestinal absorption i.e. en‐
ters the blood stream (Benito, Miller, 1998). Bioaccessibility includes the entire sequence of
events that take place during the digestive transformation of food into material that can be
assimilated by the body, the absorption/assimilation into the cells of the intestinal epitheli‐
um, and lastly, the presystemic metabolism (both intestinal and hepatic). Bioaccessibility
analyses can be approached using general experimental techniques (there are systematic
techniques common to all types of foods) that can be adapted to all types of claims regard‐
ing nutritional content.
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In vivo, as soon as a compound is released from its matrix in the chyme, the compound can
be transported across the intestinal epithelium into the body thereby keeping the compound
concentration low in the chyme.
Different analytical approaches can be applied to measure bioaccessibility of nutrients and
bioactive compounds: in vivo and in vitro studies both present strengths and drawbacks.
Within in vivo studies, balance studies and tissue concentration are two strategies that allow
determination of the absorbed amount of nutrients, bioactive compounds, or their metabo‐
lites. Balance studies determine the absorbed amount by measuring the difference between
the fed and excreted amounts of the nutrient or bioactive compound. Tissue concentration
consists of monitoring the increase in plasma/serum concentration of the nutrient or bioac‐
tive compound. These approaches have been applied these approaches have been used with
both animals and humans to determine absorption of carbohydrates, minerals, vitamins,
phytochemicals, and different compounds (Benito, Miller, 1998; Hallberg, 1991). In vivo hu‐
man studies are the criterion standard approach to determine bioaccessibility of food nu‐
trients or bioactive compounds, although some experimental approaches are ethically and
technically unaffordable.
Digestion and absorption involve several different steps, and each one could cause an effect
on the nutrient or bioactive compound so that a detailed picture is not obtained with the bal‐
ance and bioassay studies. In vitro studies have been developed to simulate the physiologic
conditions and the sequence of events that occur during digestion in the human gastrointes‐
tinal tract. In a first step, an in vitro gastrointestinal method is applied to the food, mirroring
the physiochemical conditions that take place during human digestion, considering the
three areas of the human digestive system (mouth, stomach, and intestine).
The main features of the in vitro gastrointestinal methods are temperature, shaking or agita‐
tion, and the chemical and enzymatic composition of saliva, gastric juice, duodenal juice, and
bile juice (Wittsiepe, Schrey, Hack, Selenka, Wilhelm, 2001). When physical processes that oc‐
cur in vivo are not reproduced (shear, mixing, hydration, changes in conditions over time, peri‐
stalsis), the in vitro gastrointestinal model is defined as a static or biochemical model. The
dynamic models mimic the in vivo physical processes so that they take into account new varia‐
bles, such as changes on viscosity of the digesta, particle size reduction, diffusion, and parti‐
tioning of nutrients. Several examples of in vitro gastrointestinal static and dynamic models
have been described (Rotard, Christmann, Knoth, Mailahn, 1995; Arcand, Mainville, Farn‐
worth, 2007). During the application of the in vitro gastrointestinal method, food nutrients or
bioactive compounds can be monitored to determine whether they are affected by digestion
conditions (pH, enzymes) or if interactions with other food components (fiber, sucrose polyest‐
er, fat replacers) take place, which could affect efficiency of digestion. The final processed ma‐
terial of the experimental procedure is a digesta or intestinal preparation.
To analyze the lipophilic content that has been effectively incorporated to mixed micelles,
the micellar fraction can be isolated from that processed material by the application of an
ultracentrifugation protocol (Hernell, Staggers, Carey, 1999). In the digestion model, the
compounds are not removed from the chyme during digestion and therefore, bioaccesibility
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may be underestimated when saturation of the compound occurs in the chyme. Thus, one
factor potentially affecting bioaccessibility is the level of contamination.
The bioaccessibility of aflatoxin B1 in chime has been determined from nine peanut slurries
ranging from 0.6 to 14 µg/kg aflatoxin B1 (contamination level in peanuts 1.5-36 µg/kg). Afla‐
toxin B1 was almost completely mobilised from the peanut slurries during digestion evi‐
dencing a mean bioaccessibility of 94%. The concentration of aflatoxin B1 in chyme of the
two highest contaminated peanut slurries was higher than those in the calibration curve and
a smaller volume of chyme was used for analysis (Versantvoort, Oomen, Van de Kamp,
Rompelberg, Sips, 2005).
The amount of aflatoxin B1 released from the peanut slurries into the chyme is dose pro‐
portional to the contamination level in the peanut slurries. These results showed no sat‐
uration of the chyme with aflatoxin B1.  The amount of food in the digestion model was
varied  in  order  to  study  whether  release  of  the  contaminant  from its  food  matrix  was
linearly,  i.e.  whether  bioaccessibility  was  independent  from  the  amount  of  food  in  the
model.  Application of 0.5 g and 4.5 g peanut slurry in the in vitro digestion model cor‐
responds to  the  consumption of  approximately  10  and 100  g  peanuts,  respectively.  The
bioaccessibility of some bioactive compounds can be influenced by the food composition
as  observed  by  Versantvoort  et  al.  (Versantvoort,  Oomen,  Van  de  Kamp,  Rompelberg,
Sips,  2005)  that  studied  the  effects  of  different  food components  on  the  bioaccessibility
of aflatoxin B1  from peanut slurry considering an average meal. Bioaccessibilities of afla‐
toxin  B1  (108±11%)  from  6  g  food-mix  (4.5g  standard  meal  +  0.5g  peanut  slurry  +  1g
buckwheat)  were  compared to  the  bioaccessibility  of  aflatoxin B1  from 0.5g correspond‐
ing peanut slurry (83±18%) showing that the bioaccessibility of aflatoxin B1  did not vary
significantly.
11. Advanced analysis of aflatoxins in biological fluids
11.1. Sampling and sample preparation
Sampling and sample preparation remain a considerable source of error in the analytical
identification  of  aflatoxins.  Thus,  systematic  approaches  to  sampling,  sample  prepara‐
tion, and analysis are absolutely necessary to determine aflatoxins at the parts-per-billion
level.  In this regard,  specific plans have been developed and tested rigorously for some
commodities  such as  corn,  peanuts,  and tree  nuts;  sampling plans  for  some other  com‐
modities have been modeled after them. A common feature of all sampling plans is that
the entire primary sample must be ground and mixed so that the analytical test portion
has  the  same  concentration  of  toxin  as  the  original  sample.  Methods  of  sampling  and
analysis  for  the  official  control  of  mycotoxins,  including  aflatoxins,  are  laid  down  in
Commission  Regulation  No  401/2006.  This  ensures  that  the  same  sampling  criteria  in‐
tended for the control of mycotoxin content in food are applied to the same products by
the competent authorities throughout the EU and that certain performance criteria,  such
as recovery and precision, are fulfilled. In 2008, the Codex Alimentarius set a maximum
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level of 10 µg/kg total  aflatoxins in ready-to-eat almonds, hazelnuts,  and pistachios at  a
level higher than that currently in force in the EU (4 µg/kg total aflatoxins).
11.2. Solid-phase extraction
All analytical procedures include three steps: extraction, purification, and determination.
The most significant recent improvement in the purification step is the use of solid-phase ex‐
traction. Extracts are extracts are cleaned up before instrumental analysis (thin layer or liq‐
uid chromatography) to remove coextracted materials that often interfere with the
determination of target analytes.
11.3. Thin-layer chromatography
Thin layer chromatography (TLC), also known as flat bed chromatography or planar chro‐
matography is one of the most widely used separation techniques in aflatoxin analysis.
Since 1990, it has been considered the AOAC official method and the method of choice to
identify and quantitate aflatoxins at levels as low as 1 ng/g. The TLC method is also used to
screen and corroborate findings by newer, more rapid techniques.
11.4. Liquid chromatograph
Liquid chromatography (LC) is similar to TLC in many respects, including analyte applica‐
tion, stationary phase, and mobile phase. Liquid chromatography and TLC complement
each other. For an analyst to use TLC for preliminary work to optimize LC separation condi‐
tions is not unusual. Liquid chromatography methods for the determination of aflatoxins in
foods include normal-phase LC (NPLC), reversed-phase LC (RPLC) with pre- or before-col‐
umn derivatization (BCD), RPLC followed by postcolumn derivatization (PCD), and RPLC
with electrochemical detection.
11.5. Immunochemical methods
Thin layer chromatography and LC methods for determining aflatoxins in food are labo‐
rious and time consuming. Often, these techniques require knowledge and experience of
chromatographic techniques to solve separation and and interference problems. Through
advances  in  biotechnology,  highly  specific  antibody-based  tests  are  now  commercially
available that can identify and measure aflatoxins in food in less than 10 minutes. These
tests are based on the affinities of the monoclonal or polyclonal antibodies for aflatoxins.
The  three  types  of  immunochemical  methods  are  radioimmunoassay  (RIA),  enzyme-
linked  immunosorbent  assay  (ELISA),  and  immunoaffinity  column  assay  (ICA).  These
are mostly chemical  methods of  detection but still  provide an insight into the immuno‐
chemical methods such as ELISA and RIA which can used to detect aflatoxins in foods,
such as flour and starch products.
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12. Aflatoxins identity assessment
Although analytical methods might consist of different extraction, clean-up, and quantita‐
tion steps, the results of the analyses by such methods should be similar when the methods
are applied properly. Since the reliability of the quantitative data is not in question, the
problem still to be solved is the confirmation of identity of the aflatoxins. The confirmation
techniques used involve either chemical derivatization or mass spectrometry (MS).
Different analytical methods have been reported in the literature in order to facilitate the in‐
vestigation of the role of ingested aflatoxins in small volumes of human sera (Grio, Jose, Fre‐
nich, Martinez Vidal, Luis, Romero-Gonzalez, 2010; Yuanjing, Yi, Huiming, Bingnan,
Haicheng, Fanli, Miaomiao, Wei, Wendong, 2010). Aflatoxin B1 has been extracted from 1
mL or less of human sera spiked with a known concentration of aflatoxin B1 and analyzed
using high-performance liquid chromatography (HPLC) as the detection system. Several
methods have been used to analyze feed, foods and bodyfluids, human and animal plasma,
serum, milk, etc. (Santini, Ferracane, Meca, Ritieni, 2009; Rampone, Piccinelli, Aliberti, Ras‐
trelli, 2009; Monbaliu, Van Poucke, Detavernier, Dumoulin, Van De Velde, Schoeters, Van
Dyck, Averkieva, Van Peteghem, De Saeger, 2010). The ELISA (Zhu, Zhang, Hu, Xiao, Chen,
Xu, Fremy, Chu, 1987) or radioimmunoassay (RIA) methods (Groopman, Donahue, 1988;
Tang, Pang, 2009; Li, Zhang, Zang, 2009) allow the quantification of the total amount of afla‐
toxins, and results are expressed in term of aflatoxin B1 equivalents. Both methods however
involve the use of specific antibodies not commercially available. Recently immunoensors
(Sun, Yan, Tang, Zhang, 2012) and biosensor have been proposed for the analyses of myco‐
toxins in different matrices (Campàs, Garibo, Prieto-Simón, 2012).
The International Agency for Research on Cancer has classified aflatoxin B1 as a human car‐
cinogen and aflatoxins B2, G1 and G2 as possible nephrotoxic natural compounds and carci‐
nogenic to humans (IARC, 1993; Commission Regulation (EC) No. 1525/98, 1998). Due to
carryover in food and feed they are considered nowadays to have the most severe impact of
all mycotoxins on human health. Maximum residue levels have been set down to the
฀g/mL range in a wide variety of agricultural commodities, food, feed and milk, e.g. 0.01
mg/kg of aflatoxin M1 in milk for infants (Groopman, Donahue, Zhu, Chen, Wogan,1985).
Methods like liquid chromatography-mass spectroscopy (LC/MS) have been repeatedly
used for structural elucidation in metabolism on aflatoxin containing analytes and specific
matrices but only a limited number of quantitative methods have been published to deter‐
mine the more common aflatoxins present in food (Papp, Otta, Zaray, Mincsovics, 2002; Bi‐
selli, Hartig, Wegener, Hummert, 2004; Biselli, Hartig, Wegener, Hummert, 2005; Sorensen,
Elbaek, 2005; Kokkonen, Jestoi, Rizzo, 2005) milk, (Sorensen, Elbaek, 2005) cheese, (Cava‐
liere, Foglia, Pastorini, Samperi, Lagana, 2006) herbs, (Ventura, Gomez, Anaya, Diaz, Broto,
Agut, Comellas, 2004) urine, (Scholl, Musser, Groopman, 1997; Walton, Egner, Scholl, Walk‐
er, Kensler, Groopman, 2001; Egner, Yu, Johnson, Nathasingh, Groopman, Kensler, Roe‐
buck, 2003; Wang-Buhler, Lee, Chung, Stevens, Tseng, Hseu, Hu, Westerfield, Yang,
Miranda, Buhler, 2005) airborne dust (Kussak, Nilsson, Andersso, Langridge, 1995) and cig‐
arette smoke (Edinboro, Karnes, 2005).
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LC/MS has been used as a confirmation technique for the already well established, reliable and
robust LC-FL methodology (Kussak, Nilsson, Andersson, Langridge, 1995; Abbas, Williams,
Windham, Pringle, Xie, Shier, 2002; Blesa, Soriano, Molto, Marin, Manes, 2003; Abbas, Cart‐
wright, Xie, Shier, 2006) and has also been used to confirm positive results of TLC and ELISA
based screening analyses. All the aflatoxins exhibit good ESI ionisation efficiency in the posi‐
tive ion mode with abundant protonated molecules [MH]+ and sodium adduct ions (Blesa, Sor‐
iano, Molto, Marin, Manes, 2003; Ventura, Gomez, Anaya, Diaz, Broto, Agut, Comellas, 2004;
Kussak, Nilsson, Andersson, Langridge, 1995) and typically, for aflatoxins B1, B2, G1 and G2, the
formation of sodium adduct ions can easily be suppressed by the addition of ammonium ions
to the mobile phase leading to a better mass spectroscopy (MS) sensitivity (Cavaliere, Foglia,
Pastorini, Samperi, Lagana, 2006). Reports about the utility of atmospheric pressure chemical
ionization (APCI) interfaces and ionization efficiencies in this mode seem to be highly depend‐
ent on the aflatoxin studied and the APCI interface geometry (Abbas, Williams, Windham,
Pringle, Xie, Shier, 2002; Abbas, Cartwright, Xie, Shier, 2006).
This method has been proved to be more sensitive for the simultaneous determination of
aflatoxins B1, B2, G1, G2, M1, M2, and moreover smaller sample volumes of serum can be used
for the analysis. Aflatoxins are in free equilibrium with the albumin combined form and it is
reported in the literature the effect of pH and/or serum concentration of fatty acids on the
formation of the adducts. Moreover, a recent study showed that green tea polyphenols
might modulate the formation of the adducts between aflatoxin B1 and albumin (Tang,
Tang, Xu, Luo, Huang, Yu, Zhang, Gao, Cox, Wang, 2008).
Advanced spectrometric methods, such as LC-MS/MS, permit quantification and recogni‐
tion of the free aflatoxins in the sera with fewer problems on recovery, sensitivity and chem‐
ical identification (Santini, Ferracane, Meca, Ritieni, 2009; Huang, Zheng, Zengxuan,
Yongjiang, Yiping, 2010) evaluating the aflatoxin exposure directly from their free forms.
13. Decontamination, detoxification, exposition
Aflatoxin produced by Aspergillus flavus, A. parasiticus and A. nomius crops contamination, is
a worldwide food safety concern. Several strategies, including chemical, physical and bio‐
logical control methods have been investigated to manage these potent toxic secondary me‐
tabolites in foods. Among them, biological control seems nowadays to be the most
promising approach for the aflatoxins control. From the food safety point of view, fermenta‐
tion with microorganisms, a technique quite commonly used in food production (e.g. fer‐
mentation with lactic acid bacteria, alcoholic fermentation, conventional fermentation of the
protein from vegetables as common in South Asia, etc.) should be preferred. In optimal con‐
ditions, this procedure can result in a mycotoxin-free food or feed.
The reaction of aflatoxins to various physical conditions and reagents have been studied ex‐
tensively because of the possible application of such reactions to the detoxification of afla‐
toxins contaminated material. Aflatoxins in dry state are stable to heat up to the melting
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point. However, in the presence of moisture and at elevated temperatures there is destruc‐
tion of aflatoxin and this can occur with aflatoxin in oilseed meals, roasted peanuts or in
aqueous solution at pH 7. Although the reaction products have not been examined in detail
it seems likely that such treatment leads to opening of the lactone ring with the possibility of
decarboxylation at elevated temperatures. At a temperature of about 100°C, ring opening
followed by decarboxylation occurs, and reaction may proceed further, leading to the loss of
the methoxy group from the aromatic ring.
In alkali solution reversible hydrolysis of the lactone moiety occurs. Recyclization has been
observed after acidification of a basic aflatoxin containing solution.
In the presence of acids, aflatoxin B1 and G1 are converted in to aflatoxin B2A and G2A due to
acid-catalyzed addition of water to the double bond in the furan ring. In the presence of ace‐
tic anhydride and hydrochloric acid the reation proceeds further to give the acetoxy deriva‐
tive. Similar adducts of aflatoxin B1 and G1 are formed with formic acid-thionyl chloride,
acetic acid-thionyl chloride and trifluoroacetic acid.
Many oxidizing agents, e.g. sodium hypochlorite, potassium permanganate, chlorine, hy‐
drogen peroxide, ozone and sodium perborate react with aflatoxin and change the aflatoxin
molecule in some way as indicated by the loss of fluorescence. The mechanisms of these re‐
actions are uncertain and the reaction products remain unidentified in most cases. Reduc‐
tion of aflatoxin B1 and B2 with sodium borohydride yielded aflatoxin RB1 and RB2,
respectively. These arise as a result of opening of the lactone ring followed by reduction of
the acid group and reduction of the keto group in the cyclopentene ring. Hydrogenation of
aflatoxin B1 and G1 yields aflatoxin B2 and G2 respectively. Further reduction of aflatoxin B1
using 3 moles of hydrogen yields tetrahydroxyaflatoxin.
Food and feed contaminated with mycotoxins pose a severe health risk to animals and they
may cause big economical losses due to the lower efficacy of animal husbandry and crop
performances.
In addition, directly or indirectly (carry on through animal products) contaminated foods
may also pose a health risk to humans. For this reason it is understandable that many re‐
search has been addressed in an attempt to salvage mycotoxin contaminated commodities
and to avert health risks associated with the toxins.
Relevant basic criteria to be followed when a decontamination strategy is assessed have
been suggested (Scott, 1990; Pomeranz, Bechtel, Sauer, Seitz, 1990):
• the mycotoxin must be inactivated (destroyed) by transformation to non-toxic com‐
pounds;
• fungal spores and mycelia should be destroyed, so that new toxins are not produced;
• the food or feed material should retain its nutritive value and remain palatable for con‐
sumers;
• the physical properties of raw material should not change significantly;
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• it must be economically feasible (the cost of decontamination should be less than the val‐
ue of contaminated commodity).
The main three possibilities to avoid any possible harmful effects of contamination of food
and feed caused by mycotoxins habe been described by Halàsz et al. (Halasz, Lasztity, Abo‐
nyi, Bata, 2009):
• prevention of contamination;
• decontamination of mycotoxin-containing food and feed;
• inhibition of absorption of mycotoxin in consumed food in the digestive tract.
Although the different methods used at present are to some extent successful, they have big
disadvantages with limited efficacy and possible losses of important nutrients and normally
with high costs. It is a common opinion that the best solution for decontamination should be
detoxification by biodegradation, giving a possibility for removal of mycotoxins under mild
conditions without using harmful chemicals without significant losses in nutritive value and
palatability of decontaminated food and feed. One of the most frequently used strategies for
biodegradation of mycotoxins includes isolation of microorganisms able to degrade the giv‐
en mycotoxin and treatment of food or feed in an appropriate fermentation process.
Thousand of microorganisms habe been screened for their ability to degrade aflatoxins from
solutions (Lillehoj, Ciegler, Hall, 1967; Ciegler, Lillehoj, Peterson, Hall, 1996). As a result it
was found that only one bacterium, the Flavobacterium aurantiacum B-184, was able to elimi‐
nate aflatoxin from solutions and uptake of the mycotoxin by the cells was influenced by pH
and temperature.
Another interesting result was that an high concentration populations of the cells, more than
1011 per mL, is more useful to remove the aflatoxin from solutions than lower cell concentra‐
tions. Large populations of heat inactivated cells were also shown to bind some aflatoxin
from solution, which was easily recovered by washing with water (Line, Brackett, 1967). The
ability of Flavobacterium aurantiacum B-184 to remove aflatoxins from foods was demonstrat‐
ed in milk, vegetable oil, corn, peanut, peanut butter and peanut milk (Hao, Brackett, 1988;
Hao, Brackett, 1989; Line, Brackett, 1995). To assess the exact fate of the aflatoxin B1 treated
with Flavobacterium aurantiacum, Line et al. used radio-labeled carbon (C14) aflatoxin B1 and
detected the formed radioactive carbon dioxide confirming this way the biodegradation
pathway of aflatoxin (Line, Brackett, Wilkinson, 1994).
It should be noted that the interest of the biological approach to degrade aflatoxin is increas‐
ing since the consumers prefer this tool to chemical treatments used on food and feed to
eliminate aflatoxins.
Nevertheless, one of the big obstacle to the developing of biological approaches is the bright
pigmentation associated with the bacterium treatment, that hampers the applicability for
food and feed. Microorganisms that are able to degrade aflatoxin B1 include Corynebacterium
rubrum, Aspergillus niger, Trichoderma viride, Mucor ambiguus, Dactylium dendroides, Mucor gri‐
seocyanus, Absidia repens, Helminthosporium sativum, Mucor alternans, Rhizopus archisus, Rhizo‐
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pus oryzae, Rhizopus solonifer and a protozoan Tetrahymena pyriformis (Doyle, Applebaum,
Brackett, Marth, 1982; Karlovsky, 1999).
Recently, a growing interest can be observed concerning the use of Rhodococci for aflatoxins
degradation: these microorganisms have a wide-range ability to degrade compounds like
aflatoxins (Alberts, Engelbrecht, Steyn, Holzapfel, van Zyl, 2006; Teniola, Addo, Brost, Farb‐
er, Jany, Alberts, Van Zyl, Steyn, Holzapfel, 2005). Teniola et al. (Teniola, Addo, Brost, Farb‐
er, Jany, Alberts, Van Zyl, Steyn, Holzapfel, 2005) reported the degradation of aflatoxin B1
using liquid cultures of Rhodococcus erythropolis and the analysis of the intracellular extracts
separated from Rhodococcus erythropolis liquid cultures suggested that a cascade of enzymat‐
ic reactions with loss of fluorescence (the intact aflatoxin is a fluorescent compound and
degradation results in loss of fluorescence in time) occurred. Aflatoxin B1 is probably de‐
graded by the same enzymes (biphenyl-dioxygenases, dihydro-diol-dehydrogenases, and
hydrolases) that are involved in catabolic pathways of polychlorinated biphenyls. Knowl‐
edge of gene coding for these enzymes may be helpful in development and production of
new effective enzyme preparations for degradation of aflatoxins. The role of trace metal ions
in microbial aflatoxin B1 degradation has been studied studied by Souza et al. (Souza, Brack‐
ett, 1998) who found that copper and zinc ions may inhibit the degradation of aflatoxin B1 by
Flavobacterium aurantiacum. This effect is probably connected with an influence on the en‐
zyme system involved in the degradation process. Peltonen et al. (Peltonen, El-Nezami, Sal‐
minen, Ahokas, 2000) and El Nezami et al. (El-Nezami, Kankaanpaa, Salminen, Ahokas,
1998) studied the ability of dairy strains of lactic acid bacteria to bind Aflatoxin B1. It has
been observed that Lactobacillus rhamnosus can significantly remove Aflatoxin B1 compared
with other strains. Removal was observed as very rapid, with 80% of toxin removed within
the first 60 min of treatment.
Several bacterial species, such as Bacillus, Lactobacilli, Pseudomonas, Ralstonia and Burkholderia
spp., have shown ability to inhibit fungal growth and production of aflatoxins by Aspergillus
spp. in laboratory tests. Palumbo et al. (Palumbo, Baker, Mahoney, 2006) reported that a
number of Bacillus, Pseudomonas, Ralstonia and Burkholderia strains could completely inhibit
A. flavus growth. B.subtilis and P. solanacearum strains isolated from maize soil were also able
to inhibit aflatoxin accumulation. In most cases, although these strains were highly effective
against fungal growth and against the produced toxins in laboratory conditions, they did
not give good efficacies on field. This could be attributed to the difficulty to bring the bacte‐
rial cells to the Aspergillus infection sites on commodities under field conditions. Saprophytic
yeast species, such as Candida krusei and Pichia anomala, have revealed promising efficacy as
biocontrol agents for aflatoxins decontamination (Yin, Yan, Jiang, Ma, 2008). In a similar
way to bacterial agents, these yeast strains were able to significantly inhibit Aspergillus
growth and resultant toxins in laboratory conditions. Shetty et al. (Shetty, Hald, Jespersen,
2007) observed that the ability of S. cerevisiae to bind aflatoxin B1 was strain specific with 7
strains binding 10-20%, 8 strains binding 20-40% and 3 strains binding more than 40% of the
added aflatoxin B1. Though the yeasts are considered to be potential biocontrol agents for
the aflatoxins management, further experiments conducted on field are necessary to test
their efficacies in reducing aflatoxin contamination in real on field situations.
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Many reports exists on the use of physically separated yeast cell walls obtained from brew‐
ery as feed additive in poultry diet resulting in amelioration of aflatoxins toxic effects (Shet‐
ty, Jespersen, 2003; (Santin, Paulillo, Maiorka, Okada Nakaghi, Macari, Fischer da Silva,
Alessi, 2003). When dried, yeast and yeast cell walls have been added to rat-ration along
with aflatoxin B1, and a significant reduction in the toxicity has been observed (Baptista et
al., 2004). In an in vitro study with the cell wall material, there was a dose dependent bind‐
ing of as much as 77% (w/w) and modified mannan-oligosaccharides derived from the S.
cerevisiae cell resulted in as much as 95% (w/w) binding (Girish and Devegowda, 2006).
14. Conclusions
Total quality of food is the main goal to reach and a mission both for food industry and for
the world Government Institutions. Quality means also safety, and this aspect is the most
relevant goal to pursue and achieve. Consumers have often prejudicials ideas about risks as‐
sociated to food and feed; nowadays based on the information available, they tend to have a
quite large knowledge about genetically modified microorganisms, phytopharmaceutical
origin active principles, heavy metals contamination or unbalanced dietary habit. These are
the main issues for the majority of the people. However, the perceived risk related to myco‐
toxin occurrence in food is very neglected and underestimated.
Aflatoxins are a serious problem for human health, and it is not possible to evaluate this
threat without paying great attention to the exposure to these compounds. The frequency
and level of mycotoxin presence in the food chain are grown up in the last decades, proba‐
bly due to the changed global weather conditions, to the market globalisation, and to the
worldwide deployment of mold. The development of new analytical methods, more sensi‐
tive and more specific to evaluate aflatoxins presence, ensures the managment of the risk
and, consequently, could allow to guarantee the safety of food from aflatoxin contamination.
It is not possible however to completely avoid aflatoxins contamination in the food chain
since the colonisation by molds and their mycotoxins biosynthesis are not under the full hu‐
mans control due to many different biological, genetic and biochemical reasons.
Consumers, together with safety food agencies and with the worldwide research, must max‐
imize efforts to reduce the global aflatoxin exposure. Focus should not be given only to Afla‐
toxin B1 for which the neologism ALARA where this acronym say "As Low As Reasonably
Achievable" has been considered applicable.
It can be noted as final remark that, in general, consumers do not appreciate any chemical
procedure, e.g. the use of alkali or acid solutions. The same results to control unwanted afla‐
toxins presence are achievable using ammonium or different physical or chemical ap‐
proaches. Another aspect regards the develop of a biological protocols that use
microrganism generally recognised as safe for food (GRAS), a procedure that is considered
much more acceptable by the consumers. Nevertheless, aflatoxins fate should be determined
considering also the toxicological bioactivities of aflatoxins byproducts, like their many me‐
tabolites. It is important to determine these aspects before to propose new microrganisms
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able to detoxify aflatoxins without causeing any unwanted side effect, e.g. changes in senso‐
rial and technological properties of foods. In addition, any new method should be economi‐
cally convenient if compared with any actually used procedure, especially for food industry
that may hamper for these economic reasons.
Safe food is a non-negotiable topic both for ethic reasons and for economic aspects. The so‐
cial costs linked to an increase of health conditions like liver diseases, or the problems con‐
nected to crop destruction, withdrawal of food from the shelves, etc., can be more expensive
than a preventive actions to reduce aflatoxin presence in the food chain.
Author details
Antonello Santini1* and Alberto Ritieni2
*Address all correspondence to: asantini@unina.it
1 Department of Food Science, University of Napoli “Federico II”, Portici, Napoli, Italy
2 Department of Pharmaceutical and Toxicological Chemistry, University of Napoli “Federi‐
co II”, Napoli, Italy
References
[1] Abbas, H. K., Cartwright, R. D., Xie, W., & Shier, W. T. (2006). Aflatoxin and fumoni‐
sin contamination of corn (maize, Zea mays) hybrids in Arkansas. Crop Prot. , 25(1),
1-9.
[2] Abbas, H. K., Williams, W. P., Windham, G. L., Pringle, H. C., Xie, W., & Shier, W. T.
(2002). Aflatoxin and Fumonisin Contamination of Commercial Corn (Zea mays) Hy‐
brids in Mississippi. J. Agric. Food Chem. , 50, 5246-5254.
[3] Abdel-Wahhab, M. A., Ahmed, H. H., & Hagazi, M. M. (2006). Prevention of aflatox‐
in B1-initiated hepatotoxicity in rat by marine algae extracts. J. Appl. Toxicol. , 26,
229-238.
[4] Alberts, J. F., Engelbrecht, Y., Steyn, P. S., Holzapfel, W. H., & van Zyl, W. H. (2006).
Biological degradation of aflatoxin B1 by Rhodococcus erythropolis cultures.
Int.J.Food Microbiol. , 109, 121-126.
[5] Arcand, Y., Mainville, I., & Farnworth, E. R. (2007). A dynamic model that simulates
the human upper gastrointestinal tract for the study of probiotics. Int. J. Food Micro‐
biol. , 99, 287-96.
Aflatoxins: Risk, Exposure and Remediation
http://dx.doi.org/10.5772/52866
365
[6] Artursson, P., , P., & Karlsson, J. (1991). Correlation between oral drug absorption in
humans and apparent drug permeability coefficients in human intestinal epithelial
(Caco-2) cells. Biochemical and Biophysical Research Communications, 880 EOF-885 EOF.
[7] Autrup, H., Bradly, K. A., Shamsuddin, A. K. M., Wakhisi, J., & Wasunna, A. (1983).
Detection of putative adduct with fluorescence characteristics identical to 2,3-dihy‐
dro-2-(7′-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang’a dis‐
trict, Kenya. Carcinogesis, , 4(9), 1193-1195.
[8] Barber, M. D., Mc Millan, D. C., Wallace, A. M., Ross, J. A., & Preston, T. (2004). The
response of leptin, interleukin-6 and fat oxidation to feeding in weight-losing pa‐
tients with pancreatic cancer. Br. J. Cancer. , 90, 1129-1132.
[9] Benito, P., & Miller, D. (1998). Iron absorption and bioavailability: an updated re‐
view. Nutr. Res. , 18, 581-603.
[10] Bennett, J. W., & Klich, M. (2003). Mycotoxins. Clinical Microbiology Reviews. , 16(3),
497-516.
[11] Bennett, J. W., Chang, P. K., & Bhatnagar, D. (1997). One gene to whole pathway: the
role of norsolorinic acid in aflatoxin research. Adv. Appl. Microbiol. , 45, 1-15.
[12] Berry, C. L. (1988). The pathology of mycotoxins. J. Pathol. , 154, 301-311.
[13] Biselli, S., Hartig, L., Wegener, H., & Hummert, C. (2004). Analysis of Fusarium Tox‐
ins using LC/MS-MS: Application to Various Food and Feed Matrices. Recent Appli‐
cations in LC-GC Eur. , 17, 25-31.
[14] Biselli, S., Hartig, L., Wegener, H., & Hummert, C. (2005). Analysis of Fusarium Tox‐
ins Using LC-MS-MS: Application to Various Food and Feed Matrices. Spectrosco‐
py. , 20(2), 20-28.
[15] Blesa, J., Soriano, J. M., Molto, J., Marin, C., , R., & Manes, J. J. (2003). Determination
of aflatoxins in peanuts by matrix solid-phase dispersion and liquid chromatogra‐
phy. J. Chromatogr. A. , 1011, 49-54.
[16] Blout, W. P. (1961). Turkey "X" disease. Turkeys 9:52, 55-58.
[17] Bolognani, F., Rumney, C. J., & Rowland, R. (1997). Influence of carcinogen binding
by lactic acid producing bacteria on tissue distribution and in vivo mutagenicity of
dietary carcinogens. Food Chem. Toxicol. , 35, 535-545.
[18] Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991). Selective G to T mutations of
gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431., 53.
[19] Brown, D. H., Yu, J. H., Kelkar, H. S., Fernandes, M., Nesbitt, T. C., Keller, N. P.,
Adams, T. H., & Leonard, T. J. (1996). Twenty-five co-regulated transcripts define a
sterigmatocystin gene cluster in Aspergillus nidulans. Proc. Natl. Acad. Sci. USA , 93,
1418-1422.
Aflatoxins - Recent Advances and Future Prospects366
[20] Campàs, M., Diana, Garibo. M., & Prieto-Simón, B. (2012). Novel nanobiotechnologi‐
cal concepts in electrochemical biosensors for the analysis of toxins. Analyst. , 137,
1055-1067.
[21] Cary, J. W., Chang, P. K., & Bhatnagar, D. (2001). Clustered metabolic pathway genes
in filamentous fungi, In Khachatourians G. G. and Arora D. K. (Ed.), Applied mycol‐
ogy and biotechnology, Vol. I. Agriculture and food production. Elsevier Science,
Amsterdam, The Netherlands., 165-198.
[22] Cavaliere, C., Foglia, P., Pastorini, E., Samperi, R., & Lagana, A. (2006). Liquid chro‐
matography/tandem mass spectrometric confirmatory method for determining afla‐
toxin M1 in cow milk: Comparison between electrospray and atmospheric pressure
photoionization sources. J. Chromatogr. A. 1101(1-2):69-78.
[23] Chapot, B., & Wild, C. P. (1991). ELISA for quantification of aflatoxin-albumin ad‐
ducts and their application to human exposure assessment. In: Van-Warhol, M., Vel‐
zen, D., Bullock, G.R. (Eds.), Techniques in Diagnostic Pathology (New York:
Academic Press, , 2, 135-155.
[24] Ciegler, A., Lillehoj, B., Peterson, R. E., & Hall, H. H. (1966). Microbial detoxification
of aflatoxin. Appl. Microbiol. , 14, 934-939.
[25] Cleveland, T. E., & Bhatnagar, D. (1992). Molecular strategies for reducing aflatoxin
levels in crops before harvest, In D. Bhatnagar and T. E. Cleveland (ed.), Molecular
approaches to improving food quality and safety. Van Nostrand Reinhold, New
York (USA)., 205-228.
[26] Commission, Regulation. . E. C., No, 1525/9., amending, Regulation. . E. C., No, 184/.,
setting, maximum., residue, levels., for, certain., contaminants, in., & foodstuffs, Offi‐
cial. J. Eur. Commun. L 201/43, (1998).
[27] Cotty, P. J., Bayman, P., Egel, D. S., & Elias, K. S. (1994). Agriculture, aflatoxins and
Aspergillus, In Powell, K. A., Renwick, A., Peberdy, J. F. (Ed.). The genus Aspergil‐
lus. Plenum Press, New York (USA)., 1-27.
[28] Coulombe, R. A., & Jr , . (1994). Nonhepatic effects and Biotransformations of aflatox‐
in B1, In Eaton, D.L., Groopman, J.D. (Eds.). The Toxicology of Aflatoxins: Human
Health, Veterinary and Agricultural Significance. Academic Press, Orlando (USA).,
89-110.
[29] Cullen, J. M., & Newberne, P. N. (1994). Acute heptoxotoxicity of aflatoxins. In Eaton
D. L. and Groopman J. J. (Ed.). The toxicity of aflatoxins. Human health, veterinary,
and agricultural significance. Academic Press, San Diego (USA)., 3-26.
[30] Deger, G. E. (1976). Aflatoxin-human colon carcinogenesis? Ann. Intern. Med. , 85,
204-205.
[31] Detroy, R. W., Lillehoj, E. B., & Ciegler, A. (1971). Aflatoxin and related compounds,
In Ciegler, A., Kadis, S., Ajl S.J. (Ed.). Microbial toxins. vol. VI: fungal toxins. Aca‐
demic Press, New York (USA)., 3-178.
Aflatoxins: Risk, Exposure and Remediation
http://dx.doi.org/10.5772/52866
367
[32] Diener, U. L., Cole, R. J., Sanders, T. H., Payne, G. A., Lee, L. S., & Klich, M. A. (1987).
Epidemiology of aflatoxin formation by Aspergillus flavus. Annu. Rev. Phytopa‐
thol. , 25, 249-270.
[33] Doyle, M. P., Applebaum, R. S., Brackett, R. E., & Marth, H. (1982). Physical, Chemi‐
cal and Biological Degradation of Mycotoxins. Foods and Agricultural Commodities.
J. of Food Protection. , 45, 964-971.
[34] Eaton, D. L., & Gallagher, E. P. (1994). Mechanisms of aflatoxin carcinogenesis. An‐
nu. Rev. Pharmacol. Toxicol. , 34, 135-172.
[35] Eaton, D. L., Groopman, J. D. ., & Ed., . (1994). The toxicology of aflatoxins: human
health, veterinary, and agricultural significance. Academic Press, San Diego (USA).
[36] Eaton, D. L., & Ramsdel, H. S. (1992). Species and diet related differences in aflatoxin
biotransformation, In Bhatnagar, D., Lillehoj, E.B., Arora, D.K. (Ed.), Handbook of
applied mycology, mycotoxins in ecological systems. Marcel Dekker, Inc., New York
(USA)., 5, 157-182.
[37] Eaton, D. L., Ramsdell, H. S., & Neal, G. E. (1994). In Eaton, D.L., Groopman, J.D.
(Editors). The Toxicology of Aflatoxins. Academic Press, San Diego, CA (USA)., 45.
[38] Edinboro, L. E., & Karnes, H. T. (2005). Determination of aflatoxin B1 in sidestream
cigarette smoke by immunoaffinity column extraction coupled with liquid chroma‐
tography/mass spectrometry. J. Chromatogr. A. 1083 (1-2), 127-132.
[39] Egner, P. A., Yu, X., Johnson, J. K., Nathasingh, C. K., Groopman, J. D., Kensler, T.
W., & Roebuck, B. D. (2003). Identification of Aflatoxin M1-N7-Guanine in Liver and
Urine of Tree Shrews and Rats Following Administration of Aflatoxin B1. Chem. Res.
Toxicol. , 16, 1174-1180.
[40] El -Nezami, H., Kankaanpaa, P., Salminen, S., & Ahokas, J. (1998). Ability of dairy
strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food
Chem.Toxicol. , 36, 321-326.
[41] Garrett, D. A., Failla, M. L., & Sarama, R. J. (1999). Development of an in vitro diges‐
tion method to assess carotenoid bioavailability from meals. J. Agric. Food Chem. ,
47, 4301-4309.
[42] Girish, C. K., & Devegowda, G. (2006). Efficacy of Glucomannan-containing Yeast
Product (Mycosorb) and Hydrated Sodium Calcium Aluminosilicate in Preventing
the Individual and Combined Toxicity of Aflatoxin and T-2 Toxin in Commercial
Broilers. Asian-Australian J. Anim. Sci. , 19, 877-883.
[43] Glahn, R. P., Wien, E. M., Van Campen, D. R., & Miller, D. D. (1996). Caco-2 cell iron
uptake from meat and casein digests parallels in vivo studies: use of a novel in vitro
method for rapid estimation of iron bioavailability. J. Nutr. , 126, 332-339.
[44] Goldblatt, L., & (ed., . (1969). Aflatoxin. scientific background, control, and implica‐
tions. Academic Press, New York, N.Y.
Aflatoxins - Recent Advances and Future Prospects368
[45] Goto, T., Wicklow, D. T., & Ito, Y. (1996). Aflatoxin and cyclopiazonic acid produc‐
tion by a sclerotium-producing Aspergillus tamarii strain. Appl. Environ. Microbiol. ,
62, 4036-4038.
[46] Gratz, S., Mykkänen, H., Ouwehand, A. C., Juvonen, R., & Salminen, S. (2004). Intes‐
tinal mucus alters the ability of probiotic bacteria to bind aflatoxin B1 in vitro. Appl.
Environ. Microbiol. , 70, 6306-6308.
[47] Gratz, S., Täubel, M., Juvonen, R. O., Viluksela, M., & Turner, P. C. (2006). Lactobacil‐
lus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxici‐
ty of aflatoxin B1 in rats. Appl. Environ. Microbiol. , 72, 7398-7400.
[48] Grio, L., Jose, S., Frenich, G., Martinez, Vidal. A., Luis, J., & Romero-Gonzalez, R.
(2010). J. Sep. Sci. , 33, 502-510.
[49] Groopman, J. D., Donahue, K., Zhu, J., Chen, J., & Wogan, G. N. (1985). Aflatoxin me‐
tabolism in humans: Detection of metabolites and nucleic adducts in urine by affinity
chromatography. Proc. Natl. Acad. Sci. USA. , 82, 6492-6496.
[50] Guarisco, J. A., Hall, J. O., Coulombe, R. A., & Jr , . (2008). Mechanisms of butylated
hydroxytoluene chemoprevention of aflatoxicosis-inhibition of aflatoxin B1 metabo‐
lism. Toxicol. Appl. Pharmacol. , 227, 339-346.
[51] Halasz, A., Lasztity, R., Abonyi, T., & Bata, A. (2009). Decontamination of Mycotoxin-
Containing Food and Feed by Biodegradation. Food Reviews International. , 25,
284-298.
[52] Hallberg, L. (1981). Bioavailability of dietary iron in man. Ann. Rev. Nutr. , 1, 123-47.
[53] Hao, D. Y. Y., & Brackett, R. E. (1988). Removal of aflatoxin B1 from peanut milk ino‐
culated with Flavobacterium aurantiacum J.Food Sci. , 53, 1384-1386.
[54] Hao, D. Y. Y., & Brackett, R. E. (1989). Growth and survival of Flavobacterium auran‐
tiacum in peanut milk. J.Food Protect. , 52, 165-168.
[55] Hayes, A. W. (1980). Mycotoxins: a review of biological effects and their role in hu‐
man diseases. Clin. Toxicol. , 17, 45-83.
[56] Hayes, R. B., van Nienwenhuise, J. P., Raatgever, J. W., & Ten, Kate. F. J. W. (1984).
Aflatoxin exposure in the industrial setting: an epidemiological study of mortality.
Food Chem. Toxicol. , 22, 39-43.
[57] Heathcote, J. G., & Hibbert, J. R. (1978). Aflatoxins: chemical and biological aspects.
Elsevier Scientific Publishing Company, Amsterdam, The Netherlands.
[58] Hendrickse, R. G. (1997). Of sick turkeys, kwashiorkor, malaria, perinatal mortality,
heroin addicts and food poisoning: research on the influence of aflatoxins on child
health in the tropics. Ann. Trop. Med. Parasitol. , 91, 787-793.
[59] Henry, S. H., Bosch, F. X., Troxell, T. C., & Bolger, P. M. (1999). Reducing liver can‐
cer-global control of aflatoxin. Science. , 286, 2453-2454.
Aflatoxins: Risk, Exposure and Remediation
http://dx.doi.org/10.5772/52866
369
[60] Henry, S. H., Bosch, F. X., & Bowers, J. C. (2002). Aflatoxin, hepatitis and worldwide
liver cancer risks, In DeVries, J.W., Trucksess, M.W., Jackson, L.S. (Ed.). Mycotoxins
and food safety. Kluwer Academic/Plenum Publications., New York, N.Y. (USA).,
229-320.
[61] Hernandez-Mendoza, A., Garcia, H. S., & Steele, J. L. (2009). Screening of Lactobacil‐
lus casei strains for their ability to bind aflatoxin B1. Food Chem. Toxicol. , 47,
1064-1068.
[62] Hernandez-Mendoza, A., Guzman-de-Peña, D., & Garcia, H. S. (2009). Key role of tei‐
choic acids on Aflatoxin B1 binding by probiotic bacteria. J. Appl. Microbiol. , 107,
395-403.
[63] Hernell, O., Staggers, J. E., & Carey, M. C. (1999). Physical-chemical behavior of diet‐
ary and biliary lipids during intestinal digestion and absorption: phase analysis and
aggregation states of luminal lipids during duodenal fat digestion in healthy adult
human beings. Biochem. , 29, 2041-56.
[64] Hicks, J. K., Shimizu, K., & Keller, N. P. (2002). Genetics and biosynthesis of aflatox‐
ins and sterigmatocystin, In F. Kempken (ed.), The mycota, vol. XI. Agricultural ap‐
plications. Springer-Verlag, Berlin, Germany., 55-69.
[65] Hsieh, D. (1988). Potential human health hazards of mycotoxins, In Natori, S., Hashi‐
moto, K., Ueno, Y. (Ed.), Mycotoxins and phytotoxins. Third Joint Food and Agricul‐
ture Organization W.H.O. United Nations Program International Conference of
Mycotoxins. Elsevier, Amsterdam, The Netherlands., 69-80.
[66] Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991).
Mutational hotspot in the gene in human hepatocellular carcinomas. Nature
350:377-378., 53.
[67] Huang, B., Zheng, H., Zengxuan, C., Yongjiang, W., & Yiping, R. (2012). Simultane‐
ous determination of aflatoxins B1, B2, G1, G2, M1 and M2 in peanuts and their de‐
rivative products by ultra-high-performance liquid chromatography-tandem mass
spectrometry. Anal. Chim. Acta. , 662, 62-68.
[68] IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. (1993). Inter‐
national Agency for Research on Cancer, Lyon, France. , 489.
[69] International Agency for Research on Cancer. (1982). The evaluation of the carcino‐
genic risk of chemicals to humans. IARC Monograph Supplement 4. International
Agency for Research on Cancer, Lyon, France.
[70] Karlovsky, P. (1999). Biological detoxification of fungal toxins and its use in plant
breeding, feed and food production. Nat. Toxins. , 7, 1-23.
[71] Klein, P. J., Buckner, R., Kelly, J., Coulombe Jr, , & , R. A. (2000). Biochemical basis for
the extreme sensitivity of turkeys to aflatoxin B1. Toxicol. Appl. Pharmacol. , 165,
45-52.
Aflatoxins - Recent Advances and Future Prospects370
[72] Klich, M. A. (1987). Relation of plant water potential at flowering to subsequent cot‐
tonseed infection by Aspergillus flavus. Phytopathology , 77, 739-741.
[73] Klich, M. A., Mullaney, E. J., Daly, C. B., & Cary, J. W. (2000). Molecular and physio‐
logical aspects of aflatoxin and sterigmatocystin biosynthesis by A. tamarii and A.
ochraceoroseus. Appl. Microbiol. Biotechnol. , 53, 605-609.
[74] Klich, M. A., & Pitt, J. I. (1988). Differentiation of Aspergillus flavus from Aspergillus
parasiticus and other closely related species. Trans. Br. Mycol. Soc. , 91, 99-108.
[75] Klich, M. A., Yu, J., Chang, P. K., Mullaney, E. J., Bhatnagar, D., & Cleveland, T. E.
(1995). Hybridization of genes involved in aflatoxin biosynthesis to DNA of aflatoxi‐
genic and nonaflatoxigenic aspergilli. Appl. Microbiol. Biotechnol. , 44, 439-443.
[76] Kokkonen, M., Jestoi, M., & Rizzo, A. (2005). Determination of selected mycotoxins in
mould cheeses with liquid chromatography coupled to tandem with mass spectrom‐
etry. Food Addit. Contam. , 22, 449-456.
[77] Krishnamachari, K. A. V. R., Bhat, R. V., Nagarajan, V., & Tilnak, T. M. G. (1975).
Hepatitis due to aflatoxicosis. An outbreak in Western India. Lancet. , 1, 1061-1063.
[78] Kussak, A., Nilsson, C. A., Andersson, B., & Langridge, J. (1995). Determination of
aflatoxins in dust and urine by liquid chromatography/electrospray ionization tan‐
dem mass spectrometry. Rapid Commun. Mass Spectrom. , 9(13), 1234-1237.
[79] Li, F. Q., Yoshizawa, T., Kawamura, S., Luo, S. Y., & Li, Y. W. (2001). Aflatoxins and
fumonisins in corn from the high-incidence area for human hepatocellular carcinoma
in Guangxi, China. J. Agric. Food Chem. , 49, 4122-4126.
[80] Lillehoj, E. B., Ciegler, A., & Hall, H. H. (1967). Aflatoxin B1 uptake by Flavobacteri‐
um aurantiacum and resulting toxic effects. J. Bacteriology. , 93, 464-471.
[81] Line, E. J., Brackett, R. E., & Wilkinson, R. E. (1994). Evidence for degradation of afla‐
toxin B1 by Flavobacterium aurantiacum. J. Food Protect. , 57, 788-791.
[82] Line, J. E., & Brackett, R. E. (1995). Factors affecting aflatoxin B1 removal by Flavo‐
bacterium aurantiacum. J. Food Protect. , 58, 91-94.
[83] Line, J. E., & Brackett, R. E. (1995). Role of toxin concentration and second carbon
source in microbial transformation of aflatoxin B1. J. of Food Protect. , 58, 1042-1044.
[84] Low, A. G. (1990). Nutritional regulation of gastric secretion, digestion and empty‐
ing. Nutr. Res. Rev. , 3, 229-252.
[85] Maurice, D. V., Bodine, A. B., & Rehrer, N. J. (1983). Metabolic effects of low aflatoxin
B1 levels on broiler chicks. Appl. Environ. Microbiol. , 45, 980-984.
[86] Mc Connell, E. L., Basit, A. W., & Murdan, S. (2008). Measurements of rat and mouse
gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experi‐
ments. J. Pharm. Pharmacol. , 60, 63-70.
Aflatoxins: Risk, Exposure and Remediation
http://dx.doi.org/10.5772/52866
371
[87] Minekus, M., Marteau, P., Havenaar, R., & Huis, . (1995). In Veld, J.H.J. A multicom‐
partimental dynamic computer-controlled model simulating the stomach and small
intestine. ATLA , 23, 197-209.
[88] Monbaliu, S., Van Poucke, C., Detavernier, C., Dumoulin, F., van De Velde, M., Scho‐
eters, E., van Dyck, S., Averkieva, O., Van Peteghem, C., & De Saeger, S. (2010). J. Ag‐
ric. Food Chem. , 58, 66-75.
[89] Newberne, P. M., & Butler, W. H. (1969). Acute and chronic effect of aflatoxin B1 on
the liver of domestic and laboratory animals: a review. Cancer Res. , 29, 236-250.
[90] Pawlowski, N. E., Schoenhard, G. L., Lee, D. J., Libbey, L. M., Loveland, P. M., &
Sinnhuber, R. O. (1977). Reduction of aflatoxin B1 to aflatoxicol. J. Agric. Food Chem.
25(2), , 437-438.
[91] Oomen, A. G., Hack, A., Minekus, M., Zeijdner, E., Cornelis, C., Schoeters, G., Ver‐
straete, W., Wiele, T. V., Wragg, J., Rompelberg, C. J. M., Sips, A. J. A. M., & Wijnen,
J. V. (2002). Comparison of five in vitro digestion models to study the bioaccessibility
of soil contaminants. Environ. Sci. Technol. , 36, 3326-3334.
[92] O’Neil, M. J., Smith, A., & Heckelman, P. E. (2001). The Merck Index, 13th Ed., White‐
house Station, NJ, Merck & Co., (USA) , 34-35.
[93] Palumbo, J. D., Baker, J. L., & Mahoney, N. E. (2006). Isolation of bacterial antagonists
of Aspergillus flavus from almonds. Microb Ecol. , 52(1), 45-52.
[94] Payne, G., & Brown, M. P. (1998). Genetics and physiology of aflatoxin biosynthesis.
Annu. Rev. Plant Pathol. , 36, 329-362.
[95] Peers, F. G., & Linsell, C. A. (1973). Dietary aflatoxins and human liver cancer-a pop‐
ulation study based in Kenya. Br. J. Cancer. , 27, 473-484.
[96] Peltonen, K. D., El -Nezami, H. S., Salminen, S. J., & Ahokas, J. T. (2000). Binding of
aflatoxin B1 by probiotic bacteria. J. Sci. Food Agric. , 80, 1942-1945.
[97] Peterson, S. W., Ito, Y., Horn, B. W., & Goto, T. (2001). Aspergillus bombycis a new
aflatoxigenic species and genetic variation in its sibling species A. nomius. Mycolo‐
gia. , 93, 689-703.
[98] Pitt, J. I. (2000). Toxigenic fungi: which are important? Med. Mycol. , 38(1), 17-22.
[99] Pomeranz, Y., Bechtel, D. B., Sauer, D. B., & Seitz, L. M. (1990). Fusarium headblight /
scab/ in cereal grain. In Advances in Cereal Science and Technology, Pomeranz, Y.;
Ed.; AACC: St.Paul, 373-73., 10
[100] Raj, H. G., Prasanna, H. R., Mage, N., & Lotlikar, P. D. (1986). Effect of purified rat
and hamster hepatic glutathione S-transferases on the microsome mediated binding
of aflatoxin B1 to DNA. Cancer Lett. , 33, 1-9.
[101] Ramos, A. J., & Hernández, E. (1996). In situ absortion of aflatoxins in rat small intes‐
tine. Mycopathologia. , 134, 27-30.
Aflatoxins - Recent Advances and Future Prospects372
[102] Rampone, L., Piccinelli, A. L., Aliberti, L., & Rastrelli, L. (2009). Application of pres‐
surized liquid extraction in the analysis of aflatoxins B1, B2, G1 and G2 in nuts. J.
Sep. Sci. , 32, 3837-3843.
[103] Ross, R. K., Yuan, J. M., Yu, M. C., Wogan, G. N., Qian, G. S., Tu, J. T., Groopman, J.,
Gao, Y. T., & Henderson, B. E. (1992). Urinary aflatoxin biomarkers and risk of hepa‐
tocellular carcinoma. Lancet. , 339, 1413-1414.
[104] Rotard, W., Christmann, W., Knoth, W., & Mailahn, W. (1995). Bestimmung der re‐
sorptionsverfügbaren PCDD/PCDF aus Kieselrot. UWSF-Z Umweltchem Ökotox. , 7,
3-9.
[105] Ruby, M. V., Schoof, R., Brattin, W., Goldade, M., Post, G., Harnois, M., Mosby, D. E.,
Casteel, S. W., Berti, W., Carpenter, M., Edwards, D., Cragin, D., & Chappell, W.
(1999). Advances in evaluating the oral bioavailability of inorganics in soil for use in
human health risk assessment. Environ. Sci. Technol. , 33, 3697-3705.
[106] Sabbioni, G., & Sepai, O. (1994). Determination of human exposure to aflatoxins, In
Sinha, K.K., Bhatnagar, K. (Ed.), Mycotoxins in agriculture and food safety. Marcel
Dekker, Inc., New York (USA)., 183-226.
[107] Santin, E., Paulillo, A. C., Maiorka, A., Okada, Nakaghi. L. S., Macari, M., Fischer,
da., Silva, A. V., & Alessi, A. C. (2003). Evaluation of the Efficacy of Saccharomyces
cerevisiae Cell Wall to Ameliorate the Toxic Effects of Aflatoxin in Broilers. Interna‐
tional J. Poultry Sci. , 2(5), 341-344.
[108] Santini, A., Ferracane, R., Meca, G., & Ritieni, A. (2009). Overview of analytical meth‐
ods for beauvericin and fusaproliferin in food matrices. Anal. Bioanal. Chem. , 395,
1253-1258.
[109] Scholl, P. F., Musser, S. M., & Groopman, J. D. (1997). Synthesis and Characterization
of Aflatoxin B1 Mercapturic Acids and Their Identification in Rat Urine. Chem. Res.
Toxicol. , 10, 1144-1151.
[110] Scott, P. M. (1990). Trichothecenes in grain. Cereal Foods World, , 35, 661-665.
[111] Shank, R. C., Bhamarapravati, N., Gordon, J. E., & Wogan, G. N. (1972). Dietary afla‐
toxins and human liver cancer. IV. Incidence of primary liver cancer in two munici‐
pal populations in Thailand. Food Cosmet. Toxicol. , 10, 171-179.
[112] Shetty, P. H., & Jespersen, L. (2003). Trends in Food Science & Technology Saccharo‐
myces cerevisiae and lactic acid bacteria as potential mycotoxin decontaminating
agents. International Journal of Poultry Science. , 2(5), 341-344.
[113] Shetty, P. H., Hald, B., & Jespersen, L. (2007). Surface binding of aflatoxin B1 by Sac‐
charomyces cerevisiae strains with potential decontaminating abilities in indigenous
fermented foods. Int. J. Food Microbiol. , 113(1), 41-6.
[114] Smith, J. E., & Moss, M. O. (1985). Mycotoxins. Formation, analyses and significance.
John Wiley and Sons Ed., Chichester, United Kingdom.
Aflatoxins: Risk, Exposure and Remediation
http://dx.doi.org/10.5772/52866
373
[115] Sorensen, L. K., & Elbaek, T. H. (2005). Determination of mycotoxins in bovine milk
by liquid chromatography tandem mass spectrometry. J. Chromatogr. B. , 820(2),
183-196.
[116] Souza, D. H., & Brackett, R. E. (1998). The role of trace metal ions in aflatoxin B1 deg‐
radation by Flavobacterium aurantiacum J.Food Protect. , 61, 1666-1669.
[117] Squire, R. A. (1981). Ranking animal carcinogens: a proposed regulatory approach.
Science. , 214, 877-880.
[118] Sudakin, D. L. (2003). Dietary Aflatoxin Exposure and Chemoprevention of Cancer:
A Clinical Review. Clinical Toxicology. , 41(2), 195-204.
[119] Sun, X., Yan, L., Tang, Y., & Zhang, Y. (2012). A rapid and specific immunosensor for
the detection of aflatoxigenic Aspergilli. European Food Research and Technology. ,
234(6), 1013-1021.
[120] Takahashi, T., Chang, P. K., Matsushima, K., Yu, J., Abe, K., Bhatnagar, D., Cleve‐
land, T. E., & Koyama, Y. (2002). Nonfunctionality of Aspergillus sojae aflR in a
strain of Aspergillus parasiticus with a disrupted aflR gene. Appl. Environ. Micro‐
biol. , 68, 3737-3743.
[121] Tang, L., Tang, M., Xu, L., Luo, H., Huang, T., Yu, J., Zhang, L., Gao, W., Cox, S. B., &
Wang, J. S. (2008). Modulation of aflatoxin biomarkers in human blood and urine by
green tea polyphenols intervention. Carcinogenesis. , 29(2), 411-417.
[122] Taranto, M. P., Medici, M., Perdigon, G., Ruiz-Holgado, A. P., & Valdez, G. F. (2000).
Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J.
Dairy Sci. , 83, 401-403.
[123] Teniola, O. D., Addo, P. A., Brost, I. M., Farber, P., Jany, K. D., Alberts, J. F., van Zyl,
W. H., Steyn, P. S., & Holzapfel, W. H. (2005). Degradation of aflatoxin B1 by cell-free
extracts of Rhodococcus erythropolis and Mycobacterium fluoranthenivorans sp.
Nov. Int. J. Food Microbiol. , 105, 111-117.
[124] Townsend, C. A. (1997). Progress towards a biosynthetic rationale of the aflatoxin
pathway. Pure Appl. Chem. , 58, 227-238.
[125] Trail, F., Mahanti, N., & Linz, J. (1995). Molecular biology of aflatoxin biosynthesis.
Microbiology , 141, 755-765.
[126] Valeur, N., Engel, P., Carbajal, N., Connolly, E., & Ladefoged, K. (2004). Colonization
and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastroin‐
testinal tract. Appl. Environ. Microbiol. , 70, 1176-1181.
[127] van Egmond, H. P. (1989). Aflatoxin M1: occurrence, toxicity, regulation, In H. P. van
Egmond (ed.), Mycotoxins in dairy products. Elsevier Applied Science, London
(UK)., 11-55.
[128] van het, Hof. K. H., West, C. E., Weststrate, J. A., & Hautvast, J. G. A. J. (2000). Diet‐
ary factors that affect the bioavailability of carotenoids. J. Nutr. , 130, 503-506.
Aflatoxins - Recent Advances and Future Prospects374
[129] van Rensburg, S. J., Cook-Mazaffari, P., van Schalkwyk, D. J., van der Watt, J. J., Vin‐
cent, T. J., & Purchase, I. F. (1985). Heptatocellular carcinoma and dietary aflatoxin in
Mozambique and Transkei. Br. J. Cancer , 51, 713-720.
[130] Ventura, M., Gomez, A., Anaya, I., Diaz, J., Broto, F., Agut, M., & Comellas, L. (2004).
Determination of aflatoxins B1, G1, B2 and G2 in medicinal herbs by liquid chroma‐
tography-tandem mass spectrometry. J. Chromatogr. A. , 1048, 25-29.
[131] Verma, R. J. (2004). Aflatoxin cause DNA damage. Int. J. Hum. Genet. , 4, 231-236.
[132] Versantvoort, C. H. M., Oomen, A. G., Van de Kamp, E., Rompelberg, C. J. M., &
Sips, A. J. A. M. (2005). Applicability of an in vitro digestion model in assessing the
bioaccessibility of mycotoxins from food Food and Chemical Toxicology. , 43(1),
31-40.
[133] Walton, M., Egner, P., Scholl, P. F., Walker, J., Kensler, T. W., & Groopman, J. D.
(2001). Liquid Chromatography Electrospray-Mass Spectrometry of Urinary Aflatox‐
in Biomarkers: Characterization and Application to Dosimetry and Chemopreven‐
tion in Rats. Chem. Res. Toxicol. , 14(7), 919-926.
[134] Wang-Buhler, J. L., Lee, S. J., Chung, W. G., Stevens, J. F., Tseng, H. P., Hseu, T. H.,
Hu, C. H., Westerfield, M., Yang, Y. H., Miranda, C. L., & Buhler, D. R. (2005).
CYP2K6 from zebrafish (Danio rerio): Cloning, mapping, developmental/tissue ex‐
pression, and aflatoxin B1 activation by baculovirus expressed enzyme. Comp. Bio‐
chem. Physiol., Part C Toxicol. And Pharmacol. , 140(2), 207-219.
[135] Ward, J. M., Sontag, J. M., Weisburger, E. K., & Brown, C. A. (1975). Effect of life time
exposure to aflatoxin B1 in rats. J. Natl. Cancer Inst. , 55, 107-113.
[136] Watson, A. J., Fuller, L. J., Jeens, D. J., & Archer, D. B. (1999). Homologues of aflatox‐
in biosynthesis genes and sequence of aflR in Aspergillus oryzae and Aspergillus so‐
jae. Appl. Environ. Microbiol. , 65, 307-310.
[137] Wei, C. I., Marshall, M. R., & Hsieh, D. P. H. (1985). Characterization of water-soluble
glucuronide and sulphate conjugates of aflatoxin B1. Urinary excretion in monkey,
rat and mouse. Food Chem. Toxicol. , 23, 809-819.
[138] Wei, D. L., & Jong, S. C. (1986). Production of aflatoxins by strains of the Aspergillus
flavus group maintained in ATCC. Mycopathologia. , 93, 19-24.
[139] Wienk, K. J. H., Marx, J. J. M., & Beynen, A. C. (1999). The concept of iron bioavaila‐
bility and its assessment. Eur. J. Nutr. , 38, 51-75.
[140] Wild, C. P., Umbenhauer, D., Chapot, B., & Montesano, R. (1986). Monitoring of indi‐
vidual human exposure to aflatoxins (AF) and N-nitrosamines (NNO) by immunoas‐
says. J. Cell. Biochem. , 30(2), 171-179.
[141] Wilson, D. M., & Payne, G. A. (1994). Factors affecting Aspergillus flavus group in‐
fection and aflatoxin contamination of crops, In Eaton D. L. and Groopman J. D.
Aflatoxins: Risk, Exposure and Remediation
http://dx.doi.org/10.5772/52866
375
(Ed.). The toxicology of aflatoxins. Human health, veterinary and agricultural signifi‐
cance. Academic Press. San Diego (USA)., 309-325.
[142] Wittsiepe, J., Schrey, P., Hack, A., Selenka, F., & Wilhelm, M. (2001). Comparison of
different digestive tract models for estimating bioaccessibility of polychlorinated di‐
benzo-p-dioxins and dibenzofurans (PCDD/F) from red slag ‘Kieselrot’. Int. J. Hyg.
Environ. Health. , 203, 263-73.
[143] Wogan, G. N., Edwards, G. S., & Shank, R. C. (1967). Excretion and tissue distribu‐
tion of radioactivity from aflatoxin B1- 14C in rats. Cancer Res. , 27, 1729-1736.
[144] Yin, Y. N., Yan, L. Y., Jiang, J. H., & , Z. H. (2008). Biological control of aflatoxin con‐
tamination of crops. J. Zhejiang Univ. Sci. B. (10):787-92.
[145] Yu, J., Chang, P. K., Bhatnagar, D., & Cleveland, T. E. (2000). Genes encoding cyto‐
chrome and monooxygenase enzymes define one end of the aflatoxin pathway gene
cluster in Aspergillus parasiticus. Appl. Microbiol. Biotechnol. 53:583-590., 450.
[146] Yu, J., Woloshuk, C. P., Bhatnagar, D., & Cleveland, T. E. (2000). Cloning and charac‐
terization of avfA and omtB genes involved in aflatoxin biosynthesis in three Asper‐
gillus species. Gene , 248, 157-167.
[147] Yuanjing, F., Yi, Y., Huiming, X., Bingnan, P., Haicheng, G., Fanli, M., Miaomiao, Y.,
Wei, C., & Wendong, H. (2010). Faming Zhuanli Shenqing Gongkai Shuomingshu. ,
1, 1-9.
[148] Zhu, J. Q., Zhang, L. S., Hu, X., Xiao, Y., Chen, J. S., Xu, Y. C., Fremy, J., & Chu, F. S.
(1987). Correlation of Dietary Aflatoxin B1 Levels with Excretion of Aflatoxin M1 in
Human Urine. Cancer Res. , 47(7), 1848-1852.
Aflatoxins - Recent Advances and Future Prospects376
